33rd International Symposium on Intensive Care and Emergency … · 2016. 7. 15. · Traumatic brain injury [Standard presentation] 13:30 What is the Lund concept? Per-Olof ... pro

31st International Symposium on Intensive Care and Emergency Medicine

http://www.intensive.org/1/m2I1_2.asp?L1=2&L2=1&L3=2&ety=1[07/02/2013 18:22:06]

Scientific program

Search by day Please, select a day - Search by speaker Please, choose a speaker - Search by Session types Please, choose a Session

19-March-2013

Salle HLB

Opening[Standardpresentation]

9:00 Welcome: ICUpatients aroundthe globeJean-Louis Vincent

9:20 Report of theround tableconference onneuroprotectionNino Stocchetti

Paul E Pepe

9:40 Is criticalillness adisease?John C Marshall

10:00 How to prepareand run an ICUin a masscasualty event:Experiencesfrom Oslo 2011Kjetil Sunde

10:20 Becoming abetterintensivistJohn J Marini

Albumin in brainedema[Standardpresentation]

11:00 To be avoided:The SAFEexperienceJohn Myburgh

11:15 To berecommended:The LundapproachPer-Olof Grände

11:30 Discussion

Mitochondrialdysfunction insepsis is ofparamountimportance [Pro-con debate]

11:40 Mitochondrialdysfunction insepsis is ofparamount

Gold Hall

PEEP titration [Standardpresentation]

11:00 According tolungrecruitability Luciano Gattinoni

11:15 Open lungapproach vs.ARDSnet table Robert M Kacmarek

11:30 EIT to optimizePEEP setting atthe bedside Diederik Gommers

11:45 Using lung andcardiacultrasound Antoine Vieillard-Baron

12:00 The take homemessage Neil R MacIntyre

12:15 Discussion

Traumatic braininjury[Standardpresentation]

13:30 What is theLund concept? Per-Olof Grände

13:45 Mannitol orhypertonicsaline afterTBI? Thomas Geeraerts

14:00 Management ofcerebral edema

Marek Mirski

14:15 Discussion

14:25 Revisiting ICPin traumaticbrain injury Nino Stocchetti

14:40 Monitoring

Copper Hall

Intraabdominalcompartmentsyndrome[Standardpresentation]

11:00 Transmission ofabdominalpressure to thepleural space John J Marini

11:15 Implications inthemechanicallyventilatedpatient Manu Malbrain

11:30 Decompressionfor IAH: Why,when and how Jan De Waele

11:45 Is it reallyrelevant? John C Marshall

12:00 Discussion

Optimal bloodpressure[Standardpresentation]

13:45 Vasopressorsor fluid: Whichshould comefirst? Daniel DeBacker

14:00 Use ofvasopressors inhemorrhagicshock Jacques Duranteau

14:15 Revisiting theeffects ofnorepinephrinein sepsis Jean-Louis Teboul

14:30 Discussion

14:45 Blood pressuretargets for theheart Alexandre Mebazaa

15:00 Blood pressure

Salle M (Bozar)

Resuscitation targets[Standard presentation]

11:00 SvO2: A word ofcaution Daniel De Backer

11:15 Combining ScvO2and CO2-gap Zsolt Molnar

11:30 Microcirculatoryassessment byCO2 tonometry Didier Payen

11:45 Use of lactatelevels Jan Bakker

12:00 Discussion

Sedation & analgesia[Standard presentation]

13:45 Sedation: Less ismore Thomas Strom

14:00 New approachesto monitorsedation Timothy Walsh

14:15 Sedation,immunomodulationand deliriumRobert Sanders

14:30 Discussion

14:45 Shouldbenzodiazepinesbe avoided? Timothy Girard

15:00 Is ketamine usefulin the ICU? Jaume Canet

15:15 Sedation usinginhaled agents Giuseppe Citerio

15:30 Neuromuscularblockade on theICU Marek Mirski

15:45 Discussion

16:00 Early goal-directedsedation Rinaldo Bellomo

16:15 Optimizing oursedation practicesDan Longrois

16:30 Sedation in

Tent

Removing badhumors: Truthsand fallacies[Standardpresentation]

11:00 In the liverpatient Sean Bagshaw

11:15 In the septicpatient Matthieu Legrand

11:30 Super highfluxhemofiltration Rinaldo Bellomo

11:45 Newmembranesfor CRRT inseptic AKI Patrick Honoré

12:00 Discussion

What’s happeningin the alveoli?[Standardpresentation]

13:45 Where doesthe tidalvolume go? Inez Frerichs

14:00 Continuous vsdynamic strain

Luciano Gattinoni

14:15 Respiratoryasymmetry John J Marini

14:30 Alveolarrecruitmentand lunginhomogeneity

Salvatore Grasso

14:45 Discussion

14:55 AlveolarrecruitmentanddecrementalPEEP Robert M

Silver Hall

Non-conventionalmodes ofmechanicalventilation [Standardpresentation]

11:00 High-frequencyventilation Arthur S Slutsky

11:15 High-frequencypercussiveventilation Herbert Spapen

11:30 High-frequencyoscillatoryventilation Peter Rimensberger

11:45 Neurally-adjustedventilatoryassist Antonio Pesenti

12:00 Discussion

Basicphysiologicalconcepts [Standardpresentation]

13:45 Gaseousmediators inshock: NO,H2S Peter Radermacher

14:00 Molecularmechanismsof MOF Olav Rooyackers

14:15 Putting it alltogether:Cardiacfunction,vasomotortone andeffectivecirculating

100 Hall

My ICU/ER isovercrowded![Standard presentation]

11:00 Improving ICUorganization Bertrand Guidet

11:15 Should we havestep-down units? Hannah Wunsch

11:30 Dischargingpatients from busyICUs: Does demandbreed efficiency? Scott D Halpern

11:45 Toyota lean: Usingindustrial processesto improve ICUefficiency Jeremy M Kahn

12:00 Discussion

Multiresistantorganisms[Standard presentation]

13:45 Pathogens strikeback: Escaping theimmune system Jean-Daniel Chiche

14:00 Antimicrobialoptimization in theera of increasingresistance David P Nicolau

14:15 ESBL strains in theICU: Acquisitiondoes not meantransmission Eric Maury

14:30 Pseudomonasaeruginosapneumonia: Still aproblem Massimo Antonelli

14:45 Mono orcombinationtherapy forcarbapenem-resistantenterobacteriaceae?

Matteo Bassetti

15:00 Discussion

15:15 Is there a place fornon-carbapenem

400 Hall

The obese patient[Standardpresentation]

11:00 Adapting theICU to themorbidlyobese patient Charles S Brudney

11:15 Mechanicalventilation Paolo Pelosi

11:30 FeedingPaul Wischmeyer

11:45 Antibiotictherapy Frédérique Jacobs

12:00 Discussion

Basicmechanisms: Whydo the kidneysfail?[Standardpresentation]

13:45 The conceptof renalshunting Rinaldo Bellomo

14:00 Renalhemodynamicsin sepsis:Controversiesrevisited Martin Matejovic

14:15 Ischemia orinflammation? John Prowle

14:30 Discussion

14:45 Epithelial cellinjury John Kellum

15:00 Pre-renal vsrenal injury Didier Payen

15:15 Aggravatedchronic kidneyinjuryBruce A Molitoris

15:30 Discussion

Studio (Bozar)

Metabolic alterations[Standard presentation]

11:00 Diabetes in theICU James Krinsley

11:15 Novel insightsinto the HPA axisduring criticalillness Greet Van DenBerghe

11:30 How to interprethormonemeasurements inthe critically ill? Balasubramanian Venkatesh

11:45 Sex hormonetherapies Paul E Pepe

12:00 Often forgottenelectrolytes:Phosphate Kees Polderman

12:15 Discussion

Clinical trials[Standard presentation]

13:45 Why do goodtrials yield diverseconclusions?John C Marshall

14:00 Optimal design John Myburgh

14:15 Clinical trialdesign in sepsis Derek C Angus

14:30 Discussion

14:45 Issues withconsent in theICU Niall Ferguson

15:00 Clinical trials inbrain-injuredpatients Alexis Turgeon

15:15 Clinical trials onpharmaconutrition

Paul Wischmeyer

15:30 Discussion

15:45 Rethinking

Horta Room

Obstetric emergencies[Standard presentation]

11:00 The pregnantpatient in the ICU Kees Polderman

11:15 Eclampsia andHELLP John G Laffey

11:30 Post-partumbleedingAnne-Sophie Ducloy

11:45 Amniotic fluidembolism Matthieu Legrand

12:00 Peripartumcardiomyopathy Alain Combes

12:15 Discussion

Pharmaconutrition[Standard presentation]

13:30 Fish oil andalternative lipidemulsionsWilliam Manzanares

13:45 Glutamine: Thelatest study Paul Wischmeyer

14:00 Plasma glutamineconcentration as atreatment targetJan Wernerman

14:15 Arginine / ADMA Paul Van Leeuwen

14:30 Vitamin DGreg S Martin

14:45 Some taurine? Paul Van Leeuwen

15:00 Discussion

15:15 Break

Intensive care aroundthe globe[Standard presentation]

15:45 The WorldFederation: Whatfor? Edgar Jimenez

16:00 Development ofcritical caremedicine in theAsia-Pacific region Anthony McLean



importance Jukka Takala Mervyn Singer

cerebrovascularautoregulation Geert Meyfroidt

14:55 Pediatrictraumatic braininjury Michael Bell

15:10 When tooperate Paul Vespa

15:25 Discussion

15:40 Break

16:05 Cross-talkbetween thebrain and otherorgans Paolo Pelosi

16:20 Management ofARDS in severebrain injury Robert Stevens

16:35 Targeting brainoxygenation Peter Le Roux

16:50 Discussion

17:00 Prediction ofoutcome Geert Meyfroidt

17:15 Biomarkers ofacute braininjury Mauro Oddo

17:30 Withdrawal oflife-support? Alexis Turgeon

17:45 Discussion

targets for thekidneys John Prowle

15:15 Blood pressuretargets for thebrain Nino Stocchetti

15:30 Blood pressuretargets for themicrocirculation

Daniel DeBacker

15:45 Influence oftarget arterialpressure onsurvival Pierre Asfar

16:00 The use ofvasodilators inshock: Fromtheory topractice Jan Bakker

16:15 Discussion

16:30 Break

Pancreatitis[Standardpresentation]

16:50 Newclassification Jan De Waele

17:05 Severe acutepancreatitis Pierre-François Laterre

17:20 Discussion

Oversimplifying thepro and anti-inflammatoryresponses (pl)[Plenary lecture]

17:30 Oversimplifyingthe pro andanti-inflammatoryresponses Jean-Marc Cavaillon

neurocritical carepatients Mauro Oddo

16:45 Is daily awakeningsafe in severelybrain injuredpatients?Raimund Helbok

17:00 Effects onneurocognition Marek Mirski

17:15 Discussion

Caring for ICUpatients during MRI(pl)[Plenary lecture]

17:30 Caring for ICUpatients duringMRISimon Finney

Kacmarek

15:10 Recruitmentmaneuvers inARDS:Looking forthe holy grail Paolo Pelosi

15:25 Staircase lungrecruitment isbetter thanthe40cm/40secmaneuver David Tuxen

15:40 Discussion

15:50 Break

Should wemeasuretranspulmonarypressures?[Standardpresentation]

16:10 What arethey? Davide Chiumello

16:25 What are thedeterminants?

Luciano Gattinoni

16:40 How tomeasurethem? Salvatore Grasso

16:55 Discussion

17:10 In everyARDS patient?

Antonio Pesenti

17:25 What are thepitfalls? John J Marini

17:35 So what? Laurent Brochard

17:50 Discussion

blood volume Michael Pinsky

14:30 Brain-heartinteractions Kees Polderman

14:45 Discussion

15:00 Cardiaccomplianceand elastance

Etienne Gayat

15:15 Physiologicalvignettes Arthur S Slutsky

15:30 Lung edemaduring fluidresuscitation Johan Groeneveld

15:45 Cerebralblood flowand oxygen Mauro Oddo

16:00 Discussion

16:15 Break

Cardiorespiratorybiomarkers[Standardpresentation]

16:35 Troponin intheperioperativeperiod Sean Bagshaw

16:50 Troponin inthe ICU Anthony McLean

17:05 Still a placefor othermarkers ofmyocardialnecrosis? Jonathan Ball

17:20 Discussion

Treatment of DVT(pl)[Plenary lecture]

17:35 Treatment ofDVT Beverley Hunt

beta-lactams forESBL infections Eric Maury

15:30 Role of tigecyclinein the ICU Matteo Bassetti

15:45 Inhaled colistin:Indications andeffectiveness Claude Martin

16:00 Are linezolid anddaptomycin betterthan vancomycinfor MRSA? Matteo Bassetti

16:15 Non-antibioticapproaches fortreating severeinfections Jean Chastre

16:30 Discussion

16:45 Break

Critical careultrasonography: Whatis adequate training?(RT)[Round table]

17:05 Critical careultrasonography:What is adequatetraining?Anthony McLean Antoine Vieillard-Baron Daniel De Backer Karim Bendjelid Paul H Mayo

15:45 Break

How to protectthe kidneys[Standardpresentation]

16:15 Who willdevelop AKI insepsis? Martin Matejovic

16:30 Providingmore oxygenmay not help Can Ince

16:45 Vasopressors Rinaldo Bellomo

17:00 Discussion

17:15 Puttingtogetherperfusion,filtration andoxygenationSven-Erik Ricksten

17:30 Anything new?

Michael Joannidis

17:45 Discussion

primary outcomes

Djillali Annane

16:00 Adaptive clinicaltrials William G Barsan

16:15 Health-relatedquality of lifestudies Johan Decruyenaere

16:30 Discussion

16:45 ICU length ofstay: A newapproach to achallengingoutcome Scott D Halpern

17:00 NIV in COPD:Does real-lifematch RCTresults? Laurent Brochard

17:15 Comparativeeffectivenessresearch in TBI Andrew I Maas

17:30 Can I estimate atreatment effectfromobservationaldata? Registriesvs RCTs Etienne Gayat

17:45 Discussion

16:15 Implementation ofICU medicine inlow incomecountries Marcus Schultz

16:30 The global burdenof sepsis Konrad Reinhart

16:45 Discussion

17:00 Heterogeneity ofEuropean practices Andrew Rhodes

17:15 Should we applyglobal standards ofexcellence? Khalid Shukri

17:30 What have welearned frominternationalcomparisons ofcritical care Hannah Wunsch

17:45 Discussion

20-March-2013

Gold Hall

Breathing with theventilator[Standardpresentation]

8:00 Patient-

Copper Hall

Hemodynamicmonitoring[Standard presentation]

8:00 Review of thedifferent systems

Salle M (Bozar)

The comatose patient[Standard presentation]

8:00 Biology of comaand emergence Robert Stevens

Tent

Renal dysfunction [Standard presentation]

8:00 The changingepidemiology:Results from an

Silver Hall

Safer intubation [Standardpresentation]

8:00 Airwaymanagement

100 Hall

CPR[Standard presentation]

8:00 Past, present,and future Raymond L

400 Hall

Immunomodulation[Standard presentation]

8:00 Sepsis-inducedimmunosuppression

Studio (Bozar)

Improvingcommunication[Standard presentation]

8:00 Communicationtools and toys in

Horta Room

Patient-ventilatorsynchrony (Tu)[Tutorial]

8:00 Patient-ventilator



ventilatorinteractions Neil R MacIntyre

8:15 Is synchronydesirableduring pressurecontrolledventilation? Laurent Brochard

8:30 Pressure vsvolumetargeting: Isone better? Neil R MacIntyre

8:45 Sighs do matter

Giuseppe Foti

9:00 APRV as a lungprotectivemode Neil R MacIntyre

9:15 Discussion

9:30 Reversetriggering: Theunrecognizeddyssynchrony David Tuxen

9:45 Entrainment: Anew form ofpatient-ventilatorinteraction Laurent Brochard

10:00 Autonomouscontrol ofventilation Richard Branson

10:15 Advancedautomation ofmechanicalventilation Giorgio A Iotti

10:30 Pleural effusionin ARDSpatients Davide Chiumello

10:45 Discussion

11:00 Break

Prognosis aftercardiac arrest (RT)[Round table]

11:20 Prognosis aftercardiac arrest Fabio S Taccone Jerry Nolan Mauro Oddo Raimund Helbok

Extracorporeal gas

Xavier Monnet

8:15 Transpulmonarythermodilution Nicholas Kiefer

8:30 Thermodilution-derived variablesJean-Louis Teboul

8:45 Pitfalls in themeasurement ofcardiac output Azriel Perel

9:00 Advancedhemodynamicmonitoring Gernot Marx

9:15 Assessingdiastolicdysfunction Michel Slama

9:30 Discussion

9:45 The future ofechocardiography

Jan Poelaert

10:00 Widening patientaccess to flowmonitoringMax Jonas

10:15 Non-invasivehemodynamicprofiling in theEDRichard M Nowak

10:30 The future isentirely non-invasive Charles Phillips

10:45 No, it is not Jukka Takala

11:00 Discussion

11:15 Break

Empiric antibiotictherapy for sepsis(Tu)[Tutorial]

11:35 Empiric antibiotictherapy forsepsis Thierry Calandra

Microcirculatorydamage[Standard presentation]

13:45 Glycocalyxdamage duringsepsis Markus Rehm

14:00 Microcirculatoryalterations: Timematters! Daniel DeBacker

14:15 Role of ROS in

8:15 Hepatic coma Julia Wendon

8:30 Septicencephalopathy Figen Esen

8:45 Who will eventuallywake up? Steven Laureys

9:00 Discussion

9:15 Break

Therapeutichypothermia[Standard presentation]

9:40 Protectivemechanisms Michael Bell

9:55 Defining the targettemperature Niklas Nielsen

10:10 How to coolpatients Kees Polderman

10:25 Hemodynamicmanagement Karim Bendjelid

10:40 Discussion

10:55 Effects on themicrocirculation Fabio S Taccone

11:10 Effects on the lung

Nicole Juffermans

11:25 Good for thebrain… also goodfor the heart? Kjetil Sunde

11:40 Also in severetrauma?Samuel Tisherman

11:55 Discussion

Stroke [Standard presentation]

13:45 Emergencymanagement ofintracerebralhemorrhage Joshua N Goldstein

14:00 ICU managementof intracerebralhemorrhage Paul Vespa

14:15 Endovasculartherapy in severecases Didier Payen

14:30 Discussion

14:45 Complications ofendovasculartherapy Mikael Mazighi

15:00 Reperfusionstrategies:Thrombolysis or

internationalregistry Ravindra Mehta

8:15 Pediatric researchin renal failure:How it canbenefit allpopulations Stuart Goldstein

8:30 Contrast-inducedrenal failure Eric Hoste

8:45 Is this a problemin the ICUpatient?Daniel H Kett

9:00 Discussion

9:15 Outcomes fromacute kidneyinjury not treatedby RRT Sean Bagshaw

9:30 Dopplerultrasonography Jacques Duranteau

9:45 GFRdeterminationsand plasmavolumedeterminations atthe bedsideBruce A Molitoris

10:00 Long-termoutcomes Max Bell

10:15 Discussion

How much fluid?[Standard presentation]

10:30 Beyond theFrank-Starlingmechanism Jan Bakker

10:45 Impact oninflammation andtissueoxygenation Can Ince

11:00 How much is toomuch: The holygrail of optimalfluidmanagement Berthold Bein

11:15 Renal and splenicDoppler toevaluate fluidstatus Paolo Pelosi

11:30 Timing of fluidresuscitation inseptic shock Greg S Martin

11:45 Perioperativehemodynamicgoal-directedtherapy

during CPR Jerry Nolan

8:15 Preoxygenationand intubationrevisited Samir Jaber

8:30 Still a place foretomidate? Dan Longrois

8:45 Novel videolaryngoscopes John G Laffey

9:00 Discussion

9:15 Videolaryngoscopywith reducedsedation Paul H Mayo

9:30 ETCO2monitoringreviewedMassimo Antonelli

9:45 Novel ET tubes Lorenzo Berra

10:00 Discussion

10:15 Break

Has VAP gone?[Standardpresentation]

10:35 New CDCdefinitions Marcos Restrepo

10:50 Do theserepresent a realprogress?Michael S Niederman

11:05 Surveillance ofventilator-associatedevents Robert M Kacmarek

11:20 Discussion

11:30 Markers inbronchoalveolarlavage: Dothey help? Antonio Pesenti

11:45 Update onmanagementMichael S Niederman

12:00 Discussion

Renal biomarkers[Standardpresentation]

13:45 Directiveassessment foryour favoritekidney troponin

Fowler

8:15 No ventilationCPR Paul E Pepe

8:30 Should end-tidalCO2 be usedroutinely? Kjetil Sunde

8:45 Mechanicaldevices forcardiac massage:Must-have orluxury?Giuseppe Biondi-Zoccai

9:00 Discussion

9:15 Still a role forepinephrine inCPR? Jerry Nolan

9:30 Future tool-kits incardiac arrest Paul E Pepe

9:45 When to useECMO Alain Combes

10:00 Is it worth theeffort? Daniel De Backer

10:15 Discussion

10:30 Break

New Antibiotics (Pl)[Plenary lecture]

10:50 New antibiotics Tobias Welte

Ethical problems formilitary doctors:Detainees, torture(pl)[Plenary lecture]

11:15 Ethical problemsfor militarydoctors and whyintensivistsshould beinterestedMichael Reade

Is CVP dead?[Pro-con debate]

11:40 Is CVP dead?Daniel De Backer

Daniel Reuter

Cardiorespiratorymonitoring[Standard presentation]

13:45 Basic monitoring:The neglectedessentials Berthold Bein

14:00 Ultrasoundmonitoring duringventilation Armand Mekontso

Didier Payen

8:15 We need immuno-monitoring insepsis Jean-Daniel Chiche

8:30 Aspergillosis in theacutely ill Thierry Calandra

8:45 CMV reactivation:To treat or not totreat? Gordon Rubenfeld

9:00 Herpes viridaeinfections in ICUpatients: To treator not to treat? Laurent Papazian

9:15 Discussion

My dream therapy[Standard presentation]

9:30 Vanadium for arenal hit Jan Bakker

9:45 Protease-activatedreceptors inpneumonia Tom van der Poll

10:00 CD28 antagonistsin sepsisSteven Opal

10:15 Discussion

10:25 Oxygen carriers inhemorrhagic shock Jacques Duranteau

10:40 Adenosine forischemia-reperfusion Holger K Eltzschig

10:55 Nitroprusside inCPR Paul E Pepe

11:10 Discussion

11:20 Newneuroprotectivestrategies Alan I Faden

11:35 Stem cells foracute brain injury Elisa R Zanier

11:50 Activated protein Cfor lung injury Tom van der Poll

12:05 Discussion

After cardiac arrest[Standard presentation]

13:45 Emergencycoronaryangiography forall?Giuseppe Biondi-Zoccai

14:00 The post-cardiac

the ICU Khalid Shukri

8:15 Improving wardrounds Balasubramanian Venkatesh

8:30 Improving hand-overs Daniel Reuter

8:45 Discussion

9:00 Electronic alertsin the ICU: Dothey help? Johan Decruyenaere

9:15 Surgicalstrategies: Whendo you call me?Peter Le Roux

9:30 Improvingteamwork bysimulation Luca Cabrini

9:45 Discussion

10:00 Break

Patients andfamilies[Standard presentation]

10:20 Behavioraleconomics ofintensive care Derek C Angus

10:35 Familysatisfaction Simon Finney

10:50 Conflicts withrelatives Elie Azoulay

11:05 Collateraldamage: Theimpact of criticalillness on thefamilies ofsurvivors Michael Pinsky

11:20 Discussion

Status epilepticus(Tu)[Tutorial]

11:35 Statusepilepticus Stephane Legriel

Organization:Process of care[Standard presentation]

13:45 Role of ICUorganization onpatientoutcomes Greg S Martin

14:00 Volume-outcomerelationshipsJeremy M Kahn

14:15 Transitioning the

synchrony Robert M Kacmarek

Subarachnoidhemorrhageguidelines (Tu)[Tutorial]

8:40 Subarachnoidhemorrhageguidelines Paul Vespa

Coronary syndromes(Pl)[Plenary lecture]

9:20 Coronarysyndromes Giuseppe Biondi-Zoccai

Antimicrobialstewardship:Opportunities andchallenges (Tu)[Tutorial]

9:50 Antimicrobialstewardship:Opportunitiesand challenges David P Nicolau

Right heart failure[Standardpresentation]

10:30 Due tomyocardialfailure Alexandre Mebazaa

10:45 Duringmechanicalventilation Antoine Vieillard-Baron

11:00 In severepulmonaryembolism Anthony McLean

11:15 In thepostoperativepatient Sven-Erik Ricksten

11:30 Discussion

Basic understandingof lung mechanicsfor pediatricventilation (Tu)[Tutorial]

11:45 Basicunderstandingof lungmechanics forpediatricventilation Peter Rimensberger

How we react totissue injury [Standard



exchange[Standardpresentation]

13:45 Differenttechniques fordifferent goals Antonio Pesenti

14:00 ExtracorporealCO2 removal Roberto Ronconde Albuquerque

14:15 Low-flow CO2removal inCOPD Nicholas Barrett

14:30 Discussion

14:45 Extracorporealsupport andspontaneousbreathing Luciano Gattinoni

15:00 ECMO forsevere acuterespiratoryfailure Simon Finney

15:15 For allpatients?Salvatore Grasso

15:30 Bridge to lungtransplant Giorgio A Iotti

15:45 Discussion

16:00 Expert centersor everywhere?

Michael Quintel

16:15 When and howto wean fromECMO Alain Combes

16:30 A trial ofvenovenousECMO forpneumonia isethical Alain Combes

16:45 A trial ofvenovenousECMO forpneumonia isnot ethicalDavid Tuxen

17:00 Discussion

Metabolic supportin burns (Tu)[Tutorial]

17:15 Metabolicsupport inburns Mette M

microvascularregulation Jacques Duranteau

14:30 Role ofadenosine HolgerK Eltzschig

14:45 Can inducedhyperpulsatilityimprove themicrocirculation? Didier Payen

15:00 Discussion

15:15 Break

Clinical aspects ofthe microcirculation[Standard presentation]

15:35 Newtechnologicaladvances Can Ince

15:50 In sepsis Daniel DeBacker

16:05 After surgery Rupert Pearse

16:20 Discussion

16:30 After cardiacarrest Katia Donadello

16:45 In hemorrhagicshock Jacques Duranteau

17:00 Why should webother? Jan Bakker

17:15 Discussion

Pressure-targetedventilation (Tu)[Tutorial]

17:25 Pressure-targetedventilation Laurent Brochard

clot removal? Robert Stevens

15:15 Neuroprotection:Clinical aspects Terence Valenzuela

15:30 Discussion

15:45 Break

Subarachnoidhemorrhage [Standard presentation]

16:15 Critical caremanagement Giuseppe Citerio

16:30 The role of thelectin pathway Elisa R Zanier

16:45 Global cerebraledema after SAH:An understudiedentity? Raimund Helbok

17:00 Discussion

17:15 When to transfuse Peter Le Roux

17:30 Management ofvasospasm Paul Vespa

17:45 Discussion

Christa Boer

12:00 Discussion

Cardiac failure[Standard presentation]

13:45 Inflammation incardiovasculardisease Dan Longrois

14:00 Understandingthepathophysiology Fabio Guarracino

14:15 Diastolic heartfailure Zoltan Papp

14:30 Utility ofbiomarkersSalvatore DiSomma

14:45 Altered cardiacfunction in septicshock Michel Slama

15:00 Hepaticdysfunction:Decreased bloodflow or highCVP? Alexandre Mebazaa

15:15 Discussion

15:30 Neurocardiacinteractions inacute heartfailure Anthony McLean

15:45 Atrial fibrillationin the ICU Jonathan Ball

16:00 Levosimendan:Just forhemodynamicimprovement? Zoltan Papp

16:15 Still a place foraortic ballooncounterpulsation?

Karl Werdan

16:30 Transcatheterinterventions ondiseased heartvalves Fabio Guarracino

16:45 Discussion

Fluids vs diuretics:How to decide ?[Standard presentation]

17:00 Is urine output areliable marker ofacute kidneyinjury?

Stuart Goldstein

13:55 Subclinical renalimpairment Claudio Ronco

14:05 Novelbiomarkers ofinjury Rinaldo Bellomo

14:15 We needphysiologicalbiomarkers Can Ince

14:25 Discussion

14:35 New cell-cyclearrestbiomarkers John Kellum

14:50 What’s wrongwith these newbiomarkers ? Matthieu Legrand

15:00 We need tocombinefunctional andinjurybiomarkers Ravindra Mehta

15:10 Applying all thisto clinicalpractice John Prowle

15:20 Discussion

15:35 Break

Emerging molecularbiology [Standardpresentation]

15:50 Omics fordummies Jean-Daniel Chiche

16:05 Earlyrecognition ofpathogens Steven Opal

16:20 MicroRNA as atool in the ICU Anthony McLean

16:35 MicroRNAs insepsis Roberto Ronconde Albuquerque

16:50 Discussion

17:00 Techniques forgenotyping Jean-Paul Mira

17:15 Genotyping in

Dessap

14:15 The chestradiograph isobsolete in theICU Paul H Mayo

14:30 Ventilationmonitoring usingelectricalimpedancetomography Inez Frerichs

14:45 Discussion

14:55 Ventilatorwaveforms forupper vs lowerairwayobstruction David Tuxen

15:10 Monitoring workof breathing bydiaphragmelectromyography

Antonio Pesenti

15:25 Monitoring workof breathingduring partialventilatorysupport Giuseppe Foti

15:40 Discussion

15:50 Break

16:10 Role ofextravascularlung watermeasurements Manu Malbrain

16:25 Electricalimpedancetomography forhemodynamicassessment Daniel Reuter

16:40 New non-invasivetools to evaluateleft ventricularmechanics Etienne Gayat

16:55 Brains andbreathing: Whydo not wemonitor both?Michael Ramsay

17:10 Monitoring tissueoxygenation Mervyn Singer

17:25 Discussion

How to minimizesedation (Tu)[Tutorial]

17:40 How to minimizesedation Thomas Strom

arrest syndrome Jerry Nolan

14:15 Does cardiac arrestlead to renalfailure? Ravindra Mehta

14:30 Discussion

14:40 Is hyperoxia reallybad? Evert De Jonge

14:55 Carbon dioxide: Anew target Rinaldo Bellomo

15:10 Glucose control Fabio S Taccone

15:25 PrognosisMauro Oddo

15:40 SimplifiedEEG/aEEG tomonitor the injuredbrain Hans Friberg

15:55 Discussion

16:05 Neuroimaging topredict outcome Robert Stevens

16:20 Biomarkers forhypoxic brain injuryMichael Joannidis

16:35 What questionsremain? Niklas Nielsen

16:50 Discussion

17:00 Break

Therapeutichypothermia aftercardiac arrest:Practical application(Tu)[Tutorial]

17:20 Therapeutichypothermia aftercardiac arrest:Practical application

Jerry Nolan

child to an adultICU Joe Brierley

14:30 Discussion

14:40 Thepostoperativegeriatric careunit Bruno Riou

14:55 Can we affordan open ICUmodel withlimitedresources? Massimo Antonelli

15:10 The role ofnighttimeintensivists Jeremy M Kahn

15:25 Do we reallyneedintensivists?Scott D Halpern

15:40 Discussion

15:50 Tele-ICU: Toolor toy Gernot Marx

16:05 My experiencewithtelemedicine inthe ICU Paul Vespa

16:20 Optimizingrecovery in thepost-ICU period Timothy Walsh

16:35 Discussion

Critical care in thefield[Standard presentation]

16:45 Mobile criticalcare Michael Reade

17:00 Mechanicalventilation ataltitudeRichard Branson

17:15 Blast lungtreatment Jeremy Henning

17:30 Mass events Paul E Pepe

17:45 Discussion

presentation]

13:45 The acute stressresponse Mervyn Singer

14:00 Autonomicdysfunction incritical illness Gareth Ackland

14:15 How does thehost recognizedanger? John C Marshall

14:30 Discussion

14:40 The innateresponse Thierry Calandra

14:55 Is the responseto infection sospecific? Tom van derPoll

15:10 What role forapoptosisRaquel Herrero

15:25 How age altersthis Karl Werdan

15:40 Discussion

15:50 The hiddenfactorsinfluencing thehost response Jean-Marc Cavaillon

16:05 How liverdysfunctionalters this Julia Wendon

16:20 Oxidative stress:Is it worth thestress ofthinking aboutit? Steffen Rex

16:35 The hypoxia-inflammationlink HolgerK Eltzschig

16:50 Discussion

17:00 Carbonyl stressin sepsis: Friendor foe? Stefan Hofer

17:15 Endotoxin playsan importantrole John C Marshall

17:30 Endotoxin is nota central playerin thepathophysiologyof sepsis



Berger Matthieu Legrand

17:15 Fluid overload isa more importantmarker thancreatinine Stuart Goldstein

17:30 We should usefewer diuretics inacute heartfailure Etienne Gayat

17:45 Discussion

acuteinflammation Didier Payen

17:30 Targeting theepigenomeSteven Opal

17:45 Discussion

Hiroyuki Hirasawa

17:45 Discussion

21-March-2013

Gold Hall

SSC guidelines[Standard presentation]

8:00 Surviving the newSSC Guidelines Gordon Rubenfeld

8:15 Should we use theSSC guidelines forhemodynamicresuscitation inseptic shock? YesDerek C Angus

8:25 Should we use theSSC guidelines forhemodynamicresuscitation inseptic shock? NoJean-Louis Teboul

8:35 Optimizing theemergencydepartment/ICUinterface Eddy Lang

8:50 Discussion

9:00 Resuscitation ofshock: Art versusalgorithm? Charles Phillips

9:15 Resuscitation fromsevere sepsis: Dowe need carebundles? YesArthur Van Zanten

9:25 Resuscitation fromsevere sepsis: Dowe need carebundles? NoAzriel Perel

9:35 Discussion

9:50 Poster awardsJukka Takala

Hemodynamicresuscitation in sepsis

[Standard presentation]

10:00 Temporal trends inthe epidemiologyof sepsis

Copper Hall

Fluids: When to start,when to stop?[Standard presentation]

8:00 Bedsideexamination Jukka Takala

8:15 Assessing thekidney response Johan Groeneveld

8:30 What is fluidresponsiveness? Xavier Monnet

8:45 How it is appliedin the USCharles S Brudney

9:00 Limits offunctionalhemodynamicmonitoring Michael Pinsky

9:15 Discussion

9:30 Assessing fluidresponsiveness Paul E Marik

9:45 Does it equal needfor fluids? Michael Pinsky

10:00 Also in children? Joe Brierley

10:15 How much fluid intraumatic shock?Samuel Tisherman

10:30 Discussion

10:45 Functionalhemodynamics inhigh-risk surgicalcases Azriel Perel

11:00 Assessment ofvolumeresponsiveness inspontaneouslybreathing patients

Xavier Monnet

11:15 How to assessfluid needs usingechocardiography

Salle M (Bozar)

Protecting the lungs[Standard presentation]

8:00 For everyone? Marcus Schultz

8:15 What’s the idealtidal volume? Simon Finney

8:30 Volume is moreimportant thanpressure Diederik Gommers

8:45 Discussion

9:00 Pressure is moreimportant thanvolume Niall Ferguson

9:15 Moderately high-frequencyventilation Marcelo Amato

9:30 Stress index Marco Ranieri

9:45 Discussion

10:00 Co-factors thatdetermine VILI John J Marini

10:15 NAVA as a lungprotective strategyin ARDSArthur S Slutsky

10:30 Lung recruitment:Safety, physiologyand clinicalbenefits Marcelo Amato

10:45 Applications inchildren Matthew Bacchetta

11:00 Closed loop controlof oxygenation Richard Branson

11:15 Discussion

11:30 Break

Synthetic colloidsshould be abandoned [Pro-con debate]

Tent

Antibiotic strategies[Standard presentation]

8:00 Optimalantibiotictreatment in theICU Claude Martin

8:15 Combinationantibiotictherapy forsevere infection Tobias Welte

8:30 Procalcitonin forantibioticstewardship: Isthere enoughevidence? Beat Müller

8:45 How theduration ofantibiotictherapy caninfluenceoutcome in VAP Marin Kollef

9:00 Discussion

9:15 How to optimizedosing Fabio S Taccone

9:30 The place ofinhaledantibiotics David P Nicolau

9:45 Aerosolizedantibiotics: Arethey ready totreat VAP? Jean Chastre

10:00 Discussion

Hemodynamicaspects ofrespiratory failure[Standard presentation]

10:15 Pulmonaryvasculardysfunctionduring ARDS Armand MekontsoDessap

Silver Hall

Polytrauma[Standard presentation]

8:00 Hypotensiveresuscitation fromhemorrhagic shock Samuel Tisherman

8:15 Point of careultrasound in theemergency roomSalvatore DiSomma

8:30 How to acceleratetransfer to theoperating room Giuseppe Foti

8:45 Decision-making inmultiple trauma John C Marshall

9:00 Discussion

9:15 Pelvic trauma Thomas Geeraerts

9:30 Liver trauma Julia Wendon

9:45 Spinal trauma Jacques Duranteau

10:00 New guidelines formassive bleedingJean-Louis Vincent

10:15 Discussion

10:30 Kidney injury aftermajor trauma John Prowle

10:45 Hemodynamicmonitoring: Whatshould wemeasure? Rupert Pearse

11:00 Serial lactate levelsto evaluate thepatient’s course Bruno Riou

11:15 Quality indicators intrauma care Michael Reade

11:30 Discussion

Basics of respiratory

100 Hall

In the emergencyroom[Standardpresentation]

8:00 Ultrasound forvascular access Eric Maury

8:15 Should CPAP begiven to allpatients withpulmonaryedema? Karim Bendjelid

8:30 Acute chestsyndrome insickle celldisease Armand MekontsoDessap

8:45 Utility ofbiomarkersSalvatore DiSomma

9:00 Discussion

9:15 Procalcitonin inacutely dyspneicpatientsAlan S Maisel

9:30 Severecommunity-acquiredpneumoniaprediction tools Marcos Restrepo

9:45 Riskstratificationfrom the ER todischarge Beat Müller

10:00 Discussion

10:15 High-sensitivitytroponin in theER Eddy Lang

10:30 Prasugrel vsticagrelor inacute coronarysyndromes

400 Hall

Coagulation[Standard presentation]

8:00 Optimizing heparindoses forthromboprophylaxis

Paul Wischmeyer

8:15 Bleeding withantiplatelet agents Giuseppe Biondi-Zoccai

8:30 The pathogenesisof traumaticcoagulopathy Beverley Hunt

8:45 Diagnosis of DIC insepsis Kai Zacharowski

9:00 Discussion

9:15 Management ofbleeding in sepsis Anders Perner

9:30 Coagulation andanticoagulation inliver failure Alexander Wilmer

9:45 Heparin-inducedthrombocytopenia Daniel H Kett

10:00 Discussion

Fungal infections[Standard presentation]

10:15 Beta-glucans in thediagnosis of fungalinfections Thierry Calandra

10:30 Beta-glucans toassess response totherapy Massimo Antonelli

10:45 Aspergillus intracheal aspirates:What should wedo? Stijn Blot

11:00 Can Candida causeseptic shock? Marin Kollef

11:15 Discussion

Lippens Room NationalLibrary

Neuromonitoring[Standard presentation]

8:00 Non-invasive ICPmonitoring Thomas Geeraerts

8:15 ICP or intracranialelastance Nino Stocchetti

8:30 EEG monitoring Mauro Oddo

8:45 Discussion

9:00 Multimodalitymonitoring Peter Le Roux

9:15 Evaluating theeffects ofinterventions onbrain homeostasis Raimund Helbok

9:30 Discussion

9:45 Break

Neurological crises[Standard presentation]

10:05 Update onmeningitisKees Polderman

10:20 Imagingmeningoencephalitis

Isabelle Klein

10:35 Posterior reversibleencephalopathysyndrome Stephane Legriel

10:50 Discussion

11:05 Unrecognizedseizures Marek Mirski

11:20 Metabolicencephalopathy Fabio S Taccone

11:35 Discussion

Prevention of VAP (Tu)[Tutorial]

11:50 Prevention of VAP

Studio (Bozar)

Early diagnosis ofinfection [Standard presentation]

8:00 Coagulase-negativestaphylococcusin the blood:When is it reallysignificant? Balasubramanian Venkatesh

8:15 White blood cellgene expression:Clues to theetiology ofinfection Anthony McLean

8:30 Is streptococcuspneumoniaeurinary antigenreally of interestin CAP Eric Maury

8:45 PCRmicrobiology Konrad Reinhart

9:00 Discussion

9:15 Empiric antibiotictherapy forsepsis Thierry Calandra

9:30 Do antibioticsreally matter?Mervyn Singer

9:45 US to identifythe source Eric Maury

10:00 Discussion

10:15 Break

Do we needbiomarkers?Revisited[Standard presentation]

10:40 Prognosticbiomarkers forhospitalization:



Greg S Martin

10:15 Sepsis in cirrhosisThierry Gustot

10:30 What are wetrying to correct? Fabio Guarracino

10:45 Echocardiographyto guidemanagement Anthony McLean

11:00 Continuousechocardiography: A novel approach

Jukka Takala

11:15 Discussion

11:30 Fluid resuscitationin children: Whatdoes the FEASTtrial tell us? Matthew Bacchetta

11:45 So, how muchfluid in pediatricsepsis? Joe Brierley

12:00 Blood transfusionsare needed forseptic patientsCan Ince

12:15 Fluid therapy inseptic acutekidney injury: Toomuch, too little orjust right? John Prowle

12:30 Discussion

Types of fluid: Thebasics[Standard presentation]

13:30 The basiccharacteristics ofi.v. fluids Markus Rehm

13:45 Colloids vscrystalloids: Aphysiologicalapproach Per-Olof Grände

14:00 Colloids improvethemicrocirculation Zsolt Molnar

14:15 Discussion

14:30 High viscosityfluids: Good orbad? Jacques Duranteau

14:45 Albumin: Reviewof its function andkinetics Jan Wernerman

15:00 How does HESaccumulate in thetissues? Christian J

Michel Slama

11:30 Discussion

Renal function (Tu)[Tutorial]

11:45 Renal function Bruce A Molitoris

Mechanicalventilation in ARDS[Standard presentation]

13:45 An RV protectiveapproach Antoine Vieillard-Baron

14:00 The importance ofdriving pressure Marcelo Amato

14:15 How musclerelaxants canimprove ARDSprognosis? Laurent Papazian

14:30 Role ofhypercapnia inprotective lungventilationstrategies John G Laffey

14:45 The dark side ofspontaneousventilation:Overstretch ofsub-diaphragmaticlung regions Marcelo Amato

15:00 Discussion

15:15 Spontaneousventilation forARDS: ProPaolo Pelosi

15:30 Spontaneousventilation forARDS: ConJohn J Marini

15:45 Spontaneousventilation forARDS: MaybeAntonio Pesenti

16:00 Biopsy orbronchoalveolarlavage to assessfibrosis in ARDSpatients? Laurent Papazian

16:15 Discussion

16:30 Break

VAP: Preventivemeasures[Standard presentation]

17:00 Prevention ofVAP: Newendotracheal tubetechnologies Marcos Restrepo

17:15 Novel medical

11:45 Synthetic colloidsshould beabandoned John MyburghPhilippe Van DerLinden

A new look atvasopressin[Standard presentation]

13:45 Vasopressin inhepatorenalsyndromesSean Bagshaw

14:00 A rationale forvasopressinadministration insepsis Peter Radermacher

14:15 Effects ofvasopressin onregional bloodflow Rinaldo Bellomo

14:30 Discussion

14:45 Interactionsbetweenvasopressin andsteroids Anthony Gordon

15:00 Selepressin inexperimentalsepsis Fuhong Su

15:15 Selepressin inpatients withseptic shock Jean-Louis Vincent

15:30 Discussion

15:45 Break

Liver failure [Standard presentation]

16:10 How does ‘acute’differ from ‘acute-on-chronic’ liverfailure Julia Wendon

16:35 Organ dysfunctionin the cirrhoticpatient: Lung,heart and kidney Pierre-François Laterre

16:50 Discussion

17:00 How to providesedation andanalgesia in thesepatientsMichael Ramsay

17:15 Management ofsevere alcoholichepatitis Thierry Gustot

17:30 When to

10:30 Monitoringpulmonaryartery pressureis important Antonio Pesenti

10:45 RV dysfunctionvs failureAntoine Vieillard-Baron

11:00 Discussion

11:15 Coping with thehemodynamiceffects of PEEP Jean-Daniel Chiche

11:30 Effects on rightventricularafterload: PEEPvs tidal volume Diederik Gommers

11:45 Pulmonary-renalinteractions:What toconsider? Michael Joannidis

12:00 Discussion

Energyrequirements: Howearly and howmuch?[Standard presentation]

13:45 Metabolicsyndrome incritical illnessBalasubramanian Venkatesh

14:00 Malnutrition: Anemergency inyour ICU?Paul Wischmeyer

14:15 The role ofautophagy incritical illness Greet Van DenBerghe

14:30 What influencesoxygen demand?

Mervyn Singer

14:45 Discussion

14:55 Computers areneeded tooptimizenutritionaltherapy Mette M Berger

15:10 How nutritionmay influenceoutcomes inrenal failure Rinaldo Bellomo

15:25 Optimal

physiology (Tu)[Tutorial]

11:45 Basics ofrespiratoryphysiology John G Laffey

Adjunct therapies insepsis [Standard presentation]

13:45 Hypercapnia:Benefit or harm? John G Laffey

14:00 What place forstatins? Mervyn Singer

14:15 Corticosteroids forseptic shock Djillali Annane

14:30 Discussion

14:45 Do we needanother trial onsteroids? Balasubramanian Venkatesh

15:00 What place forglutamine? Richard Griffiths

15:15 And selenium?Konrad Reinhart

15:30 Selenium: Aliterature reviewWilliam Manzanares

15:45 Discussion

16:00 Break

16:20 Macrolides asimmunomodulators Marcos Restrepo

16:35 ImmunoglobulinsZsolt Molnar

16:50 A place for anti-TLR interventions? Thierry Calandra

17:05 Reversing sepsis-induced immunesuppression John Kellum

17:20 Discussion

The agitated patient(Pl)[Plenary lecture]

17:35 The agitatedpatientMichael Reade

Giuseppe Biondi-Zoccai

10:45 Time torecanalization: Acritical goal forstroke therapy Mikael Mazighi

11:00 Accidentalhypothermia Kees Polderman

11:15 Discussion

Obstructive lungdisease[Standardpresentation]

11:30 Riskstratification inCOPD: Beyondlung function Daiana Stolz

11:45 Airflowobstruction:Lessons learnedover 30 years John J Marini

12:00 Exacerbation ofCOPD Tobias Welte

12:15 Acute severeasthma Jonathan Ball

12:30 Changingmanagementand improvingoutcome Andres Esteban

12:45 Discussion

Weaning[Standardpresentation]

13:30 How I do it Neil R MacIntyre

13:45 Clinicalimplications offailed extubation

James Krinsley

14:00 Diaphragmdysfunction:Diagnosis andmanagement Samir Jaber

14:15 Ventilatordependency:From musclewasting toweaning failureSteffen Weber-Carstens

14:30 Discussion

14:45 Weaning failureof cardiac origin

11:30 When to startantifungals inabdominalinfections: Let usbe INTENSE Jean-Louis Vincent

11:45 The place forprophylactic orpreemptive therapy

Matteo Bassetti

12:00 How to adaptantifungal drugdoses? Patrick Honoré

12:15 Are allechinocandins thesame? Matteo Bassetti

12:30 Discussion

Long-term outcomes[Standard presentation]

13:30 A recentmulticenter study Timothy Walsh

13:45 Neurocognitiveoutcomes areimportant Derek C Angus

14:00 Cerebral sequellaeafter severehypoxemia Michael Quintel

14:15 Discussion

14:30 Renal outcomesafter acute renalfailure Miet Schetz

14:45 Are long-termoutcomes anyworse than for therest of thehospital? Gordon Rubenfeld

15:00 Diabetes is notassociated withworse outcomes inthe critically ill James Krinsley

15:15 Discussion

15:30 Break

Organ donation[Standard presentation]

15:50 Management of thepotential organdonor Jonathan Ball

16:05 How to improvedonor kidneyquality Didier Payen

16:20 Can goal-directedtherapy work for

Jean Chastre

Non-invasiveventilation[Standard presentation]

13:30 Outside the ICU Luca Cabrini

13:45 For hemoncologypatients Massimo Antonelli

14:00 Should we give ‘do-not-intubate’patients NIV? Elie Azoulay

14:15 For postoperativeand traumapatients Davide Chiumello

14:30 Discussion

14:45 For obesity-hypoventilationsyndrome Antoni Torres

15:00 When not to use it David Tuxen

15:15 NIV by helmet Giorgio A Iotti

15:30 Technical/clinicalapplication of NIV Robert M Kacmarek

15:45 Discussion

16:00 Can we risksedation? Andres Esteban

16:15 Optimal analgesia Samir Jaber

16:30 SCCM latestguidelinesMichael Ramsay

16:45 Discussion

Subarachnoidhemorrhage: Criticalcare management (Pl)[Plenary lecture]

17:00 Subarachnoidhemorrhage:Critical caremanagement Giuseppe Citerio

ECMO for cardiogenicshock (Pl)[Plenary lecture]

17:30 ECMO forcardiogenic shock Alain Combes

Use and misuse Beat Müller

10:55 Are all natriureticpeptides equal? Alexandre Mebazaa

11:10 For acutecardiorenaldysfunction Alan S Maisel

11:25 Discussion

11:35 For renalfunction Max Bell

11:50 In neurologicalpatients Peter Le Roux

12:05 What do we dowith all thesebiomarkers inthe ICU? Daiana Stolz

12:20 Discussion

Electrical impedancetomography: 5-yearclinical experience(Tu)[Tutorial]

13:30 Electricalimpedancetomography: 5-year clinicalexperience Diederik Gommers

Diabeticemergencies (Tu)[Tutorial]

14:10 Diabeticemergencies Ken Hillman

The new oralanticoagulants (Tu)[Tutorial]

14:50 The new oralanticoagulants Beverley Hunt

Comparing coolingtechnologies (Tu)[Tutorial]

15:30 Comparingcoolingtechnologies Kees Polderman

Bedsidepercutaneoustracheostomy (Tu)[Tutorial]

16:10 Bedsidepercutaneoustracheostomy Marek Mirski

Managing the rightventricle (Tu)[Tutorial]

16:50 Managing the



Wiedermann

15:15 Discussion

15:30 How can HESinduce renalinjury? Gernot Marx

15:45 How can HESinducecoagulopathy? Anders Perner

16:00 HES can haveprotective effects Paolo Pelosi

16:15 Discussion

16:30 Break

Beta-stimulation orblockade? [Standard presentation]

16:50 The harmfuleffects ofcatecholamines Mervyn Singer

17:05 Beta-blockingagents Djillali Annane

17:20 Beta-blockingagents inneurologicalpatients Nino Stocchetti

17:35 Beta-blockingagents in headtraumaKees Polderman

17:50 Discussion

devices inrespiratory care Lorenzo Berra

17:30 VAP: Best practicefor diagnosis andprevention Timothy Walsh

17:45 Discussion

transplant Julia Wendon

17:45 Discussion

nutritionalsupport in renalfailure (PICARDtrial)Ravindra Mehta

15:40 Discussion

15:50 Protein intake ismore criticalthan energy Jean-Charles Preiser

16:05 Optimal proteinsupplementationof the critically ill

Jan Wernerman

16:20 My favoritefeeding strategy Alexander Wilmer

16:35 Discussion

Should weregionalize criticalcare?[Standard presentation]

16:45 Pediatricspecializedunits? Michael Bell

17:00 Cardiac arrestcenters? Jerry Nolan

17:15 ECMO centers? Nicolo Patroniti

17:30 ICUs?Jeremy M Kahn

17:45 Discussion

Xavier Monnet

15:00 Fluidmanagementduring weaning Armand MekontsoDessap

15:15 Do we needlong-termweaning units? Timothy Walsh

15:30 Discussion

15:45 Break

Biomarkers in sepsis[Standardpresentation]

16:05 Re-visiting thewhite blood cellcount Axel Nierhaus

16:20 Predictingoutcome in CAP Salvador Bello

16:35 Matureadrenomedullin Alan S Maisel

16:50 Discussion

17:00 Isadrenomedullina friend or afoe? Peter Radermacher

17:15 Combining Pro-ADM and PCT Jaap van Dissel

17:30 MetabolicprofilesAnthony Gordon

17:45 Discussion

brain-dead organdonors? John Kellum

16:35 Discussion

16:45 Organ donationafter cardiac deathin the ICU Scott D Halpern

17:00 Organ donationfrom adults tochildren? Joe Brierley

17:15 Discussion

The ICU patient withsystemic disease (Tu)[Tutorial]

17:25 The ICU patientwith systemicdisease Jean-Daniel Chiche

right ventricleMichael Pinsky

VILI (Tu)[Tutorial]

17:30 VILI Marco Ranieri

22-March-2013

Gold Hall

The recent big fluidtrials: Where tonow? [Standardpresentation]

8:00 The CHESTTrial: Furtheranalyses John Myburgh

8:15 The CRYSTALstudy Djillali Annane

8:30 HES solutionsafter 6S andCHESTDavid Gattas

8:45 The ALBIOSstudy Luciano Gattinoni

Copper Hall

Salvage therapiesin ARDS[Standardpresentation]

8:00 Refractoryhypoxemia Gordon Rubenfeld

8:15 Pronepositioning Laurent Brochard

8:30 Still a place forinhaled NO? Jean-Daniel Chiche

8:45 Still a place forHFOV? Niall Ferguson

9:00 Discussion

Salle M (Bozar)

Massive bleeding[Standardpresentation]

8:00 Hemorrhagecontrol withtourniquets anddressings Rob Russell

8:15 Warfarinreversal Christian J Wiedermann

8:30 Bleedingmanagement inthe era of noveloralanticoagulants Eddy Lang

8:45 Prothrombincomplexconcentrates vs

Tent

Glucose control:How tight?[Standardpresentation]

8:00 The influence ofcytokines onglucose levels Hiroyuki Hirasawa

8:15 Glucose, musclemetabolism andatrophy Steffen Weber-Carstens

8:30 Diabetes,dysglycemia andoutcome in theICUJames Krinsley

8:45 Glucose controlin the pediatric

Silver Hall

Before theemergency room[Standardpresentation]

8:00 Oxygenation inthe ambulance

Paolo Pelosi

8:15 Point-of-carebiology in theambulance Jan Bakker

8:30 ECMO retrievalteam Alain Combes

8:45 Discussion

9:00 CPAP outsidethe hospital Giuseppe Foti

100 Hall

Enteral feeding[Standard presentation]

8:00 Does the routereally matter? Mette M Berger

8:15 Timing matters Paul E Marik

8:30 Protocols forenteral feeding Jean-Charles Preiser

8:45 Discussion

9:00 Results of theMetaplus trial Arthur Van Zanten

9:15 Adding parenteralnutrition? Greet Van Den

400 Hall

ICU qualityassessment[Standardpresentation]

8:00 Evaluatinghealthcarequality Jan A Hazelzet

8:15 Limitations ofusing mortalityas anoutcome-indicator forbenchmarking Evert DeJonge

8:30 Newapproachesusing mortalityas a quality

Lippens RoomNational Library

Postoperativecomplications[Standardpresentation]

8:00 What is high-risk surgery? Rupert Pearse

8:15 Goal-directedhemodynamicmanagementin high-risksurgery Daniel Reuter

8:30 Outcomes inthe high-riskpatient Andrew Rhodes

Studio (Bozar)

Guidelines and bundles[Standard presentation]

8:00 Are guidelineswishful thinking? Jukka Takala

8:15 Are guidelines forantibiotic use reallyhelpful?Daniel H Kett

8:30 Cowboys in the ICU:Single patientstudies Joe Brierley

8:45 Bundle, checklistand guidelineimplementation incritical care Derek C Angus

9:00 Discussion



9:00 Discussion

9:15 Albumin inintensive care:Regulation andreimbursementissues Albert Farrugia

9:30 What aboutdifferent patientgroups? Sibylle Kozek-Langenecker

9:45 Where are wenow? Christian J Wiedermann

10:00 Discussion

10:30 Break

Composition of i.v.fluids [Standardpresentation]

10:50 Saline and thekidney: Thebasics John Kellum

11:05 The clinicalproblem withchloride-richfluids Rinaldo Bellomo

11:20 Are balancedsolutions ideal? Bertrand Guidet

11:35 Discussion

11:45 Effects ofartificial andbiologicalcolloids onrenal function Michael Joannidis

12:00 Fluid choicesfor septic shockresuscitation Greg S Martin

12:15 Discussion

Transfusion[Standardpresentation]

13:30 Are we takingtoo much bloodfrom our ICUpatients? Kai Zacharowski

13:45 Death by bloodtransfusion Paul E Marik

14:00 Anemia ortansfusion:Which isworse?

ARDS: Clinical[Standardpresentation]

9:30 Risk factors forTRALI in thecritically ill Nicole Juffermans

9:45 Coagulation andgenetics Jean-Paul Mira

10:00 Fluidmanagement inARDS Daniel Reuter

10:15 Update onpharmacologicaltherapiesCarlos SantacruzHerrera

10:30 Discussion

ARDS: Challengingthe Berlin criteria[Standardpresentation]

10:45 What are thesecriteria? Niall Ferguson

11:00 What are wereallydiagnosing? Andres Esteban

11:15 I like the Berlincriteria Laurent Brochard

11:30 I don’t likethem Charles Phillips

11:45 Discussion

ARDS: Challengingthe Berlin Criteria -Can we do better?[Round table]

12:00 ARDS:Challenging theBerlin criteria -Can we dobetter?Gordon Rubenfeld Luciano Gattinoni Marco Ranieri Michael Quintel

Niall Ferguson

Statistics fordummies (Tu)[Tutorial]

13:30 Statistics fordummies Dominique Benoit

FFPJoshuaN Goldstein

9:00 How much FFP?

Jeremy Henning

9:15 Discussion

9:30 Fibrinogen toboostcoagulation Jacques Duranteau

9:45 Coagulationmanagement inthe bleedingpatient Kai Zacharowski

10:00 Coagulationfactorconcentrates insevere bleeding

Sibylle Kozek-Langenecker

10:30 Obstetrichemorrhage Nicholas Kiefer

10:45 Discussion

11:00 Break

What I havelearned from themilitary?[Standardpresentation]

11:20 An overview ofhistoricalmedicaladvances in war

Michael Reade

11:35 Military traumasystems design Rob Russell

11:50 Military pre-hospital careJeremy Henning

12:05 Discussion

ICU: Any long-termconsequences? Greet Van DenBerghe

9:00 Glucose control:How to quantifyquality?Luc Foubert

9:15 Discussion

9:30 Impact onshort-termoutcomes inheart failure Alexandre Mebazaa

9:45 Glucosemonitoringaccuracy? Marcus Schultz

10:00 Aremeasurementsfrom blood gasanalyzerssufficient?Jean-Charles Preiser

10:15 How to reportperformance ofnear-continuousglucosemonitoring: ARound Tableconsensus Jan Wernerman

10:30 Discussion

10:45 Break

Safer tracheostomy[Standardpresentation]

11:05 Pros and consof the sixpercutaneoustechniques Luca Cabrini

11:20 Ventilationduring theprocedure Giuseppe Foti

11:35 Minimizing riskduring theprocedureAxel Nierhaus

11:50 Optimalhumidification Paolo Pelosi

12:05 Prolongedtrachealintubation ortracheostomy? Andres Esteban

12:20 Discussion

Antibiotic

9:15 The future ofemergencymedicalservices as amedicalsubspecialty Raymond L Fowler

9:30 Discussion

9:45 Break

Before the ICU[Standardpresentation]

10:05 Redefiningresuscitation Ken Hillman

10:20 Early warningsystems onnon-ICU wards

Marin Kollef

10:35 What shouldbe measured? Rinaldo Bellomo

10:40 Alternatedesigns forhospital rapidresponsesystems David Gattas

10:55 Discussion

Continuous renalreplacementtherapy (Tu)[Tutorial]

11:10 Continuousrenalreplacementtherapy Ashita Tolwani

Imaging the brain(Tu)[Tutorial]

11:50 Imaging thebrain Isabelle Klein

Renal replacementtherapy[Standardpresentation]

13:30 Timing andmodality ofRRT:Relationship tolong-termoutcomes John Kellum

13:45 How dophysiciansmake thedecision toinitiatedialysis? Ravindra Mehta

Berghe

9:30 Adding probiotics? Arthur Van Zanten

9:45 Discussion

10:00 Break

Delirium[Standard presentation]

10:20 Pathophysiology:We are lessconfused Robert Sanders

10:35 Effects of criticalillness on cognitivefunction Timothy Girard

10:50 Sleep disorders Stefan Hofer

11:05 Discussion

11:20 Noise control Philippe Jorens

11:35 Targetingneuroinflammatorypathways withimmunoglobulintreatment Figen Esen

11:50 Managing deliriumin the ICU Timothy Girard

12:05 Discussion

End-of-life care [Standard presentation]

13:30 Understandingtreatmentlimitations in theICU Rinaldo Bellomo

13:45 Non-invasiveventilation Elie Azoulay

14:00 Decisions to limitlife support in theICU: Whatexplains thevariability? Scott D Halpern

14:15 Managing dying inthe ICU Ken Hillman

14:30 Discussion

14:45 Ethics in thepediatric ICU Matthew Bacchetta

15:00 Should we bemeasuring thequality of ICUend-of-life care? Jeremy M Kahn

15:15 End of life care:From bedside tocourtroom Gordon Rubenfeld

measurement Jeremy M Kahn

8:45 The use ofprognosticmodels forbenchmarkingquality of carein TBI AndrewI Maas

9:00 Discussion

9:15 Break

The hypovolemicpatient (Tu)[Tutorial]

9:35 Thehypovolemicpatient Zsolt Molnar

CNS monitoring inthe ICU (Tu)[Tutorial]

10:05 CNSmonitoring inthe ICU Thomas Geeraerts

Respiratoryinfections [Standardpresentation]

10:55 Innateimmunity inthe lung: Howpneumoniadevelops Jean-Daniel Chiche

11:10 CAP andpneumococcalpneumonia Jean-Paul Mira

11:25 CAP: Single ordoublecoverage? Marcos Restrepo

11:40 Discussion

11:50 Corticosteroidsin CAP: A two-edged sword? Antoni Torres

12:05 Discussion

Management ofsevere hypoxemia(Pl)[Plenary lecture]

13:30 Managementof severehypoxemia Nicolo Patroniti

8:45 The surgicalpatient as amodel ofcritical illness Gareth Ackland

9:00 Discussion

9:15 Do we needbiomarkers asprognosticindicators? Jaap vanDissel

9:30 Predictionandprevention ofpostoperativepulmonarycomplications

Jaume Canet

9:45 Theimportance ofperioperativeventilatorysettings Samir Jaber

10:00 Discussion

10:15 Break

10:35 Preventingrenal failure Sean Bagshaw

10:50 Causes ofperioperativeacute kidneyinjury John Prowle

11:05 Arginine:Standard ofcare in high-risk surgery? Paul Wischmeyer

11:20 Discussion

Treating theRIGHT ventricle(Pl)[Plenary lecture]

11:35 Treating theRIGHTventricle Steffen Rex

9:15 Break

The limits of what wecan provide[Standard presentation]

9:40 How medicalemergency teamscan contribute Rinaldo Bellomo

9:55 The frail patient Sean Bagshaw

10:10 The elderly Bertrand Guidet

10:25 Discussion

10:40 The elderly burnvictim Mette M Berger

10:55 The cancer patient Elie Azoulay

11:10 Acute-on-chronicliver failure Julia Wendon

11:25 The perception ofhealth careproviders Dominique Benoit

11:40 Discussion

Thromboelastography:We should use it more[Pro-con debate]

11:55 Thromboelstographyprophylaxis: Weshould use it moreBeverley Hunt Stefan Hofer



Aryeh Shander

14:15 Effect onpostoperativemorbi-mortality: Itdepends on theindication Philippe VanDer Linden

14:30 Discussion

14:45 RBC transfusionimprovesperipheraloxygenation Johan Groeneveld

15:00 Effects oftransfusion onthemicrocirculation

Jacques Duranteau

15:15 Transfusions inneurocriticalcare: Where isthe evidence? Alexis Turgeon

15:30 Shouldeveryone havea transfusiontrigger of 7g/dL?Timothy Walsh

15:45 Discussion

16:00 ScvO2 to guidetransfusions Zsolt Molnar

16:15 Age of storedRBCs: Potentialimplications Lorenzo Berra

16:30 Age of storedRBCs: But doesit matter? Nicole Juffermans

16:45 Discussion

ARDS: New ideas[Standardpresentation]

14:10 Gene stem celltherapiesJohn G Laffey

14:25 Targetingapoptosis Raquel Herrero

14:40 Interferon betaGeoffrey Bellingan

14:55 Discussion

15:10 Heliox Nicole Juffermans

15:25 Fast CTassessment oflungrecruitability Davide Chiumello

15:40 Ion mobilityspectrometry asa bedside toolto detectvolatilecompounds Michael Quintel

15:55 Personalizedtreatmentbased ontiming?Andres Esteban

16:10 Discussion

management (Tu)[Tutorial]

13:30 Antibioticmanagement Pieter Depuydt

Nosocomialinfections[Standardpresentation]

14:10 Risk andseverity Pierre Damas

14:25 Selectivedecontaminationof the digestivetract Evert De Jonge

14:40 C. difficile in theICU Matteo Bassetti

14:55 The role ofbacterial biofilm Lorenzo Berra

15:10 Discussion

15:25 Are surveillancecultures helpful?Pieter Depuydt

15:40 Infectionprevention andcontrol by e-learning Stijn Blot

15:55 Infection controlpractices in theICU: What isthe evidence? Daniel H Kett

16:10 Can statinsimproveoutcomes? Laurent Papazian

16:25 Discussion

14:00 Still a place forperitonealdialysis? Eric Hoste

14:15 Discussion

14:30 IntermittentversuscontinuousRRT… orhybridmethods?Michael Joannidis

14:45 Does choice ofRRT modalityaffect renalrecovery? Rinaldo Bellomo

15:00 PediatricCRRT: Newhorizons Claudio Ronco

15:15 Discussion

15:30 Ideal vascularaccessPatrick Honoré

15:45 Citrateanticoagulationfor CRRT Ashita Tolwani

16:00 Practicalmanagement:Strategies toextend circuitlifespan John Prowle

16:15 Discussion

15:30 Discussion

Harnessing the powerof internet forimproved bedside care

[Demonstration ]

15:45 Harnessing thepower of theinternet forimproved bedsidecare Eddy Lang

Necrotizing skinand soft tissueinfections (Pl)[Plenary lecture]

14:00 Necrotizingskin and softtissueinfections Jan De Waele

Earlyrehabilitation[Standardpresentation]

14:30 Mechanisms ofmusclewasting in theICU Olav Rooyackers

14:45 Impact ofearlyphysiotherapyon muscle Steffen Weber-Carstens

15:00 Passivemobilization Jean-Charles Preiser

15:15 Discussion

15:30 Does thediaphragmdiffer fromlimb muscles?Samir Jaber

15:45 Total ICUrehabilitation Richard Griffiths

16:00 Discussion

33rd International Symposium on Intensive Care and Emergency Medicine


Home Symposium Perioperative Monitoring Refresher Course Echocardiography Rome Course(s)

Description Scientific prog. Abstracts Industry Social prog. Links Contact Register

Scientific program

Additional activities

Search program

Login :

Password :

Forgot your password?

List view

Scientific program

3/19/2013 - 3/20/2013 - 3/21/2013 - 3/22/2013 -

3/19/2013Salle HLB

Opening [Standard presentation] Jean-Daniel Chiche ( Paris , France) - Michael Pinsky (Pittsburgh , United States) -

9:00 Welcome: ICU patients around the globeJean-Louis Vincent ( Brussels , Belgium) -

9:20 Report of the round table conference on neuroprotectionPaul E Pepe ( Dallas , United States) -

Nino Stocchetti ( Milan , Italy) -

9:40 Is critical illness a disease?John C Marshall ( Toronto , Canada) -

10:00 How to prepare and run an ICU in a mass casualty event: Experiences fromOslo 2011Kjetil Sunde ( Oslo , Norway) -

10:20 Becoming a better intensivistJohn J Marini ( St Paul , United States) -

Albumin in brain edema [Standard presentation] Peter Le Roux ( Philadelphia, United States) -

11:00 To be avoided: The SAFE experienceJohn Myburgh ( Sydney, Australia) -

11:15 To be recommended: The Lund approachPer-Olof Grände ( Lund , Sweden) -

11:30 Discussion

Mitochondrial dysfunction in sepsis is of paramount importance [Pro-con debate] Simon Finney ( London , United Kingdom) -

11:40 Mitochondrial dysfunction in sepsis is of paramount importance PRO : Mervyn Singer ( London , United Kingdom) -

CON : Jukka Takala ( Bern , Switzerland) -

Gold HallPEEP titration [Standard presentation] Richard Branson ( Cincinatti , United States) - Inez Frerichs (Kiel , Germany) -

11:00 According to lung recruitability

Session typesPlenary Lecture

These lectures are

high level 'State-of-

the-Art' reviews and

should not be

restricted to detailed

personal studies.

Please remember this

is a clinically-oriented

eductional

symposium.

Standard

Presentation

These lectures are

high level 'State-of-

the-Art' reviews and

should not be

restricted to detailed

personal studies.

Please remember this

is a clinically-oriented

eductional

symposium. There is a

short question time

after each talk.

Workshop

The format of a

workshop is

somewhere between a

standard presentation

and a Round Table,

http://www.intensive.org/index.asp

http://www.intensive.org/choicePage.asp?ety=1





http://www.intensive.org/1/m1I1.asp?L1=1&L2=1&L3=1&ety=1


http://www.intensive.org/1/m4I1_1.asp?L1=4&L2=1&L3=1&ety=1







http://www.intensive.org/1/m9I1_new.asp?L1=9&L2=1&L3=1&ety=1

http://www.intensive.org/1/m9I1_new.asp?L1=9&L2=1&L3=1&ety=1



Luciano Gattinoni ( Milan , Italy) -

11:15 Open lung approach vs. ARDSnet table Robert M Kacmarek ( Boston , United States) -

11:30 EIT to optimize PEEP setting at the bedside Diederik Gommers ( Rotterdam , Netherlands) -

11:45 Using lung and cardiac ultrasound Antoine Vieillard-Baron ( Boulogne-Billancourt , France) -

12:00 The take home message Neil R MacIntyre ( Durham , United States) -

12:15 Discussion

Traumatic brain injury [Standard presentation] Alan I Faden ( Baltimore, United States) - Terence Valenzuela (Tucson, United States) -

13:30 What is the Lund concept? Per-Olof Grände ( Lund , Sweden) -

13:45 Mannitol or hypertonic saline after TBI? Thomas Geeraerts ( Toulouse , France) -

14:00 Management of cerebral edema Marek Mirski ( Baltimore , United States) -

14:15 Discussion

14:25 Revisiting ICP in traumatic brain injury Nino Stocchetti ( Milan , Italy) -

14:40 Monitoring cerebrovascular autoregulation Geert Meyfroidt ( Leuven , Belgium) -

14:55 Pediatric traumatic brain injury Michael Bell ( Pittsburgh, United States) -

15:10 When to operate Paul Vespa ( Los Angeles , United States) -

15:25 Discussion

15:40 Break

16:05 Cross-talk between the brain and other organs Paolo Pelosi ( Genoa , Italy) -

16:20 Management of ARDS in severe brain injury Robert Stevens ( Baltimore , United States) -

16:35 Targeting brain oxygenation Peter Le Roux ( Philadelphia, United States) -

16:50 Discussion

17:00 Prediction of outcome Geert Meyfroidt ( Leuven , Belgium) -

17:15 Biomarkers of acute brain injury Mauro Oddo ( Lausanne , Switzerland) -

17:30 Withdrawal of life-support? Alexis Turgeon ( Quebec , Canada) -

17:45 Discussion

Copper HallIntraabdominal compartment syndrome [Standard presentation]

Jonathan Ball ( London , United Kingdom) - Anthony McLean (Sydney , Australia) -

11:00 Transmission of abdominal pressure to the pleural space John J Marini ( St Paul , United States) -

with each speaker

giving a 10-15 min.

presentation (with

projection) followed

by a discussion. The

participants are

encouraged to

interact in advance to

discuss the content of

their presentation.

Pro-con debate

Each of the two

opponents present a

10-12 min.

presentation (with or

without projection) to

defend his/her views

before a general

discussion.

Tutorial

Informal teaching

session dealing

primarily with

practical aspects.

Illustrative case

presentations may be

useful. Dialog with the

audience is

encouraged.

Projection and board

can be used.

Round table

Very informal session.

The moderator invites

each participant to

present a short (2-3

min.) opening

statement before a

general discussion

(with the participation

of the audience).

There is no

projection.

Meet the experts

This is the most

informal format;

basically an informal

conversation between

two experts who

exchange their views

with the audience.

Data projection is

discouraged. An



11:15 Implications in the mechanically ventilated patient Manu Malbrain ( Antwerp , Belgium) -

11:30 Decompression for IAH: Why, when and how Jan De Waele ( Ghent , Belgium) -

11:45 Is it really relevant? John C Marshall ( Toronto , Canada) -

12:00 Discussion

Optimal blood pressure [Standard presentation] Paul E Pepe ( Dallas , United States) - Julia Wendon ( London ,United Kingdom) -

13:45 Vasopressors or fluid: Which should come first? Daniel De Backer ( Brussels , Belgium) -

14:00 Use of vasopressors in hemorrhagic shock Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

14:15 Revisiting the effects of norepinephrine in sepsis Jean-Louis Teboul ( Le Kremlin-Bicêtre , France) -

14:30 Discussion

14:45 Blood pressure targets for the heart Alexandre Mebazaa ( Paris , France) -

15:00 Blood pressure targets for the kidneys John Prowle ( London, United Kingdom) -

15:15 Blood pressure targets for the brain Nino Stocchetti ( Milan , Italy) -

15:30 Blood pressure targets for the microcirculation Daniel De Backer ( Brussels , Belgium) -

15:45 Influence of target arterial pressure on survival Pierre Asfar ( Angers , France) -

16:00 The use of vasodilators in shock: From theory to practice Jan Bakker ( Rotterdam , Netherlands) -

16:15 Discussion

16:30 Break

Pancreatitis [Standard presentation] Jan Bakker ( Rotterdam , Netherlands) - Anne-Sophie Ducloy (Lille , France) -

16:50 New classification

17:05 Severe acute pancreatitis Pierre-François Laterre ( Brussels , Belgium) -

17:20 Discussion

Oversimplifying the pro and anti-inflammatory responses (pl) [Plenary lecture]

17:30 Oversimplifying the pro and anti-inflammatory responses Jean-Marc Cavaillon ( Paris , France) -

Salle M (Bozar)Resuscitation targets [Standard presentation] Can Ince ( Amsterdam , Netherlands) - Michel Slama ( Amiens ,France) -

11:00 SvO2: A word of caution Daniel De Backer ( Brussels , Belgium) -

11:15 Combining ScvO2 and CO2-gap Zsolt Molnar ( Szeged , Hungary) -

11:30 Microcirculatory assessment by CO2 tonometry Didier Payen ( Paris , France) -

overhead projector

will be available, but

the board will be most

suitable to make a

point with drawings !



11:45 Use of lactate levels Jan Bakker ( Rotterdam , Netherlands) -

12:00 Discussion

Sedation & analgesia [Standard presentation] Diederik Gommers ( Rotterdam , Netherlands) - Max Jonas (Southampton , United Kingdom) -

13:45 Sedation: Less is more Thomas Strom ( Copenhagen, Denmark) -

14:00 New approaches to monitor sedation Timothy Walsh ( Edinburgh , United Kingdom) -

14:15 Sedation, immunomodulation and deliriumRobert Sanders ( London , United Kingdom) -

14:30 Discussion

14:45 Should benzodiazepines be avoided? Timothy Girard ( Nashville , United States) -

15:00 Is ketamine useful in the ICU? Jaume Canet ( Barcelona, Spain) -

15:15 Sedation using inhaled agents Giuseppe Citerio ( Monza , Italy) -

15:30 Neuromuscular blockade on the ICU Marek Mirski ( Baltimore , United States) -

15:45 Discussion

16:00 Early goal-directed sedation Rinaldo Bellomo ( Melbourne, Australia) -

16:15 Optimizing our sedation practicesDan Longrois ( Paris , France) -

16:30 Sedation in neurocritical care patients Mauro Oddo ( Lausanne , Switzerland) -

16:45 Is daily awakening safe in severely brain injured patients?Raimund Helbok ( Innsbruck , Austria) -

17:00 Effects on neurocognition Marek Mirski ( Baltimore , United States) -

17:15 Discussion

Caring for ICU patients during MRI (pl) [Plenary lecture] 17:30 Caring for ICU patients during MRI

Simon Finney ( London , United Kingdom) -

TentRemoving bad humors: Truths and fallacies [Standardpresentation] Pierre Asfar ( Angers , France) - Samuel Tisherman (Pittsburgh, United States) -

11:00 In the liver patient Sean Bagshaw ( Edmonton , Canada) -

11:15 In the septic patient Matthieu Legrand ( Paris , France) -

11:30 Super high flux hemofiltration Rinaldo Bellomo ( Melbourne, Australia) -

11:45 New membranes for CRRT in septic AKI Patrick Honoré ( Brussels , Belgium) -

12:00 Discussion

What’s happening in the alveoli? [Standard presentation] John G Laffey ( Toronto, Canada) - Marco Ranieri ( Turin ,



Italy) -13:45 Where does the tidal volume go?

Inez Frerichs ( Kiel , Germany) -

14:00 Continuous vs dynamic strain Luciano Gattinoni ( Milan , Italy) -

14:15 Respiratory asymmetry John J Marini ( St Paul , United States) -

14:30 Alveolar recruitment and lung inhomogeneity Salvatore Grasso ( Bari , Italy) -

14:45 Discussion

14:55 Alveolar recruitment and decremental PEEP Robert M Kacmarek ( Boston , United States) -

15:10 Recruitment maneuvers in ARDS: Looking for the holy grail Paolo Pelosi ( Genoa , Italy) -

15:25 Staircase lung recruitment is better than the 40cm/40sec maneuver David Tuxen ( Melbourne , Australia) -

15:40 Discussion

15:50 Break

Should we measure transpulmonary pressures? [Standardpresentation] Robert M Kacmarek ( Boston , United States) - Neil R MacIntyre ( Durham , United States) -

16:10 What are they? Davide Chiumello ( Milan , Italy) -

16:25 What are the determinants? Luciano Gattinoni ( Milan , Italy) -

16:40 How to measure them? Salvatore Grasso ( Bari , Italy) -

16:55 Discussion

17:10 In every ARDS patient? Antonio Pesenti ( Milan , Italy) -

17:25 What are the pitfalls? John J Marini ( St Paul , United States) -

17:35 So what? Laurent Brochard ( Geneva , Switzerland) -

17:50 Discussion

Silver HallNon-conventional modes of mechanical ventilation [Standardpresentation] Massimo Antonelli ( Rome , Italy) - Laurent Brochard ( Geneva, Switzerland) -

11:00 High-frequency ventilation Arthur S Slutsky ( Toronto , Canada) -

11:15 High-frequency percussive ventilation Herbert Spapen ( Brussels , Belgium) -

11:30 High-frequency oscillatory ventilation Peter Rimensberger ( Geneva , Switzerland) -

11:45 Neurally-adjusted ventilatory assist Antonio Pesenti ( Milan , Italy) -

12:00 Discussion

Basic physiological concepts [Standard presentation] Armand Mekontso Dessap ( Créteil , France) - Mervyn Singer (



London , United Kingdom) -13:45 Gaseous mediators in shock: NO, H2S

Peter Radermacher ( Ulm , Germany) -

14:00 Molecular mechanisms of MOF Olav Rooyackers ( Huddinge , Sweden) -

14:15 Putting it all together: Cardiac function, vasomotor tone and effectivecirculating blood volume Michael Pinsky ( Pittsburgh , United States) -

14:30 Brain-heart interactions Kees Polderman ( Pittsburgh , United States) -

14:45 Discussion

15:00 Cardiac compliance and elastance Etienne Gayat ( Paris, France) -

15:15 Physiological vignettes Arthur S Slutsky ( Toronto , Canada) -

15:30 Lung edema during fluid resuscitation Johan Groeneveld ( Rotterdam, Netherlands) -

15:45 Cerebral blood flow and oxygen Mauro Oddo ( Lausanne , Switzerland) -

16:00 Discussion

16:15 Break

Cardiorespiratory biomarkers [Standard presentation] Giuseppe Biondi-Zoccai ( Rome, Italy) - Kjetil Sunde ( Oslo ,Norway) -

16:35 Troponin in the perioperative period Sean Bagshaw ( Edmonton , Canada) -

16:50 Troponin in the ICU Anthony McLean ( Sydney , Australia) -

17:05 Still a place for other markers of myocardial necrosis? Jonathan Ball ( London , United Kingdom) -

17:20 Discussion

Treatment of DVT (pl) [Plenary lecture] 17:35 Treatment of DVT

Beverley Hunt ( London , United Kingdom) -

100 HallMy ICU/ER is overcrowded! [Standard presentation] Derek C Angus ( Pittsburgh , United States) - Pierre-François Laterre ( Brussels , Belgium) -

11:00 Improving ICU organization Bertrand Guidet ( Paris , France) -

11:15 Should we have step-down units? Hannah Wunsch ( New York , United States) -

11:30 Discharging patients from busy ICUs: Does demand breed efficiency? Scott D Halpern ( Philadelphia, United States) -

11:45 Toyota lean: Using industrial processes to improve ICU efficiency Jeremy M Kahn ( Pittsburgh , United States) -

12:00 Discussion

Multiresistant organisms [Standard presentation] Marcos Restrepo ( San Antonio , United States) - Tobias Welte( Hannover , Germany) -

13:45 Pathogens strike back: Escaping the immune system Jean-Daniel Chiche ( Paris , France) -

14:00 Antimicrobial optimization in the era of increasing resistance



David P Nicolau ( Hartford , United States) -

14:15 ESBL strains in the ICU: Acquisition does not mean transmission Eric Maury ( Paris , France) -

14:30 Pseudomonas aeruginosa pneumonia: Still a problem Massimo Antonelli ( Rome , Italy) -

14:45 Mono or combination therapy for carbapenem-resistant enterobacteriaceae? Matteo Bassetti ( Udine, Italy) -

15:00 Discussion

15:15 Is there a place for non-carbapenem beta-lactams for ESBL infections Eric Maury ( Paris , France) -

15:30 Role of tigecycline in the ICU Matteo Bassetti ( Udine, Italy) -

15:45 Inhaled colistin: Indications and effectiveness Claude Martin ( Marseille , France) -

16:00 Are linezolid and daptomycin better than vancomycin for MRSA? Matteo Bassetti ( Udine, Italy) -

16:15 Non-antibiotic approaches for treating severe infections Jean Chastre ( Paris , France) -

16:30 Discussion

16:45 Break

Critical care ultrasonography: What is adequate training? (RT) [Round table] Michel Slama ( Amiens , France) -

17:05 Critical care ultrasonography: What is adequate training?Karim Bendjelid ( Geneva , Switzerland) -

Daniel De Backer ( Brussels , Belgium) -

Paul H Mayo ( New York , United States) -

Anthony McLean ( Sydney , Australia) -

Antoine Vieillard-Baron ( Boulogne-Billancourt , France) -

400 HallThe obese patient [Standard presentation] Pierre Damas ( Liège , Belgium) - Dan Longrois ( Paris ,France) -

11:00 Adapting the ICU to the morbidly obese patient Charles S Brudney ( Durham , United States) -

11:15 Mechanical ventilation Paolo Pelosi ( Genoa , Italy) -

11:30 FeedingPaul Wischmeyer ( Aurora , United States) -

11:45 Antibiotic therapy Frédérique Jacobs ( Brussels , Belgium) -

12:00 Discussion

Basic mechanisms: Why do the kidneys fail? [Standardpresentation] Max Bell ( Stockholm, Sweden) - Holger K Eltzschig ( Aurora,United States) -

13:45 The concept of renal shunting Rinaldo Bellomo ( Melbourne, Australia) -

14:00 Renal hemodynamics in sepsis: Controversies revisited Martin Matejovic ( Plzen , Czech Republic) -

14:15 Ischemia or inflammation? John Prowle ( London, United Kingdom) -

14:30 Discussion



14:45 Epithelial cell injury John Kellum ( Pittsburgh , United States) -

15:00 Pre-renal vs renal injury Didier Payen ( Paris , France) -

15:15 Aggravated chronic kidney injuryBruce A Molitoris ( Indianapolis , United States) -

15:30 Discussion

15:45 Break

How to protect the kidneys [Standard presentation] Charles S Brudney ( Durham , United States) - Matthieu Legrand ( Paris , France) -

16:15 Who will develop AKI in sepsis? Martin Matejovic ( Plzen , Czech Republic) -

16:30 Providing more oxygen may not help Can Ince ( Amsterdam , Netherlands) -

16:45 Vasopressors Rinaldo Bellomo ( Melbourne, Australia) -

17:00 Discussion

17:15 Putting together perfusion, filtration and oxygenationSven-Erik Ricksten ( Gothenburg, Sweden) -

17:30 Anything new? Michael Joannidis ( Innsbruck , Austria) -

17:45 Discussion

Studio (Bozar)Metabolic alterations [Standard presentation] Max Jonas ( Southampton , United Kingdom) - Paul VanLeeuwen ( Amsterdam , Netherlands) -

11:00 Diabetes in the ICU James Krinsley ( Stamford , United States) -

11:15 Novel insights into the HPA axis during critical illness Greet Van Den Berghe ( Leuven , Belgium) -

11:30 How to interpret hormone measurements in the critically ill? Balasubramanian Venkatesh ( Brisbane , Australia) -

11:45 Sex hormone therapies Paul E Pepe ( Dallas , United States) -

12:00 Often forgotten electrolytes: Phosphate Kees Polderman ( Pittsburgh , United States) -

12:15 Discussion

Clinical trials [Standard presentation] Zsolt Molnar ( Szeged , Hungary) - Steven Opal ( Providence ,United States) -

13:45 Why do good trials yield diverse conclusions?John C Marshall ( Toronto , Canada) -

14:00 Optimal design John Myburgh ( Sydney, Australia) -

14:15 Clinical trial design in sepsis Derek C Angus ( Pittsburgh , United States) -

14:30 Discussion

14:45 Issues with consent in the ICU Niall Ferguson ( Toronto , Canada) -



15:00 Clinical trials in brain-injured patients Alexis Turgeon ( Quebec , Canada) -

15:15 Clinical trials on pharmaconutrition Paul Wischmeyer ( Aurora , United States) -

15:30 Discussion

15:45 Rethinking primary outcomes Djillali Annane ( Garches , France) -

16:00 Adaptive clinical trials William G Barsan ( Ann Arbor , United States) -

16:15 Health-related quality of life studies Johan Decruyenaere ( Ghent , Belgium) -

16:30 Discussion

16:45 ICU length of stay: A new approach to a challenging outcome Scott D Halpern ( Philadelphia, United States) -

17:00 NIV in COPD: Does real-life match RCT results? Laurent Brochard ( Geneva , Switzerland) -

17:15 Comparative effectiveness research in TBI Andrew I Maas ( Edegem , Belgium) -

17:30 Can I estimate a treatment effect from observational data? Registries vs RCTs Etienne Gayat ( Paris, France) -

17:45 Discussion

Horta RoomObstetric emergencies [Standard presentation] Christa Boer ( Amsterdam , Netherlands) - Jacques Duranteau (Le Kremlin-Bicêtre , France) -

11:00 The pregnant patient in the ICU Kees Polderman ( Pittsburgh , United States) -

11:15 Eclampsia and HELLP John G Laffey ( Toronto, Canada) -

11:30 Post-partum bleedingAnne-Sophie Ducloy ( Lille , France) -

11:45 Amniotic fluid embolism Matthieu Legrand ( Paris , France) -

12:00 Peripartum cardiomyopathy Alain Combes ( Paris , France) -

12:15 Discussion

Pharmaconutrition [Standard presentation] James Krinsley ( Stamford , United States) - Balasubramanian Venkatesh ( Brisbane , Australia) -

13:30 Fish oil and alternative lipid emulsionsWilliam Manzanares ( Montevideo, Uruguay) -

13:45 Glutamine: The latest study Paul Wischmeyer ( Aurora , United States) -

14:00 Plasma glutamine concentration as a treatment targetJan Wernerman ( Stockholm , Sweden) -

14:15 Arginine / ADMA Paul Van Leeuwen ( Amsterdam , Netherlands) -

14:30 Vitamin DGreg S Martin ( Atlanta , United States) -

14:45 Some taurine? Paul Van Leeuwen ( Amsterdam , Netherlands) -



15:00 Discussion

15:15 Break

Intensive care around the globe [Standard presentation] John C Marshall ( Toronto , Canada) - Michael Reade ( HerstonQLD, Australia) -

15:45 The World Federation: What for? Edgar Jimenez ( Orlando , United States) -

16:00 Development of critical care medicine in the Asia-Pacific region Anthony McLean ( Sydney , Australia) -

16:15 Implementation of ICU medicine in low income countries Marcus Schultz ( Amsterdam , Netherlands) -

16:30 The global burden of sepsis Konrad Reinhart ( Jena , Germany) -

16:45 Discussion

17:00 Heterogeneity of European practices Andrew Rhodes ( London , United Kingdom) -

17:15 Should we apply global standards of excellence? Khalid Shukri ( Kuwait City, Kuwait) -

17:30 What have we learned from international comparisons of critical care Hannah Wunsch ( New York , United States) -

17:45 Discussion

3/20/2013Gold Hall

Breathing with the ventilator [Standard presentation] Salvatore Grasso ( Bari , Italy) - John J Marini ( St Paul ,United States) -

8:00 Patient-ventilator interactions Neil R MacIntyre ( Durham , United States) -

8:15 Is synchrony desirable during pressure controlled ventilation? Laurent Brochard ( Geneva , Switzerland) -

8:30 Pressure vs volume targeting: Is one better? Neil R MacIntyre ( Durham , United States) -

8:45 Sighs do matter Giuseppe Foti ( Lecco, Italy) -

9:00 APRV as a lung protective mode Neil R MacIntyre ( Durham , United States) -

9:15 Discussion

9:30 Reverse triggering: The unrecognized dyssynchrony David Tuxen ( Melbourne , Australia) -

9:45 Entrainment: A new form of patient-ventilator interaction Laurent Brochard ( Geneva , Switzerland) -

10:00 Autonomous control of ventilation Richard Branson ( Cincinatti , United States) -

10:15 Advanced automation of mechanical ventilation Giorgio A Iotti ( Pavia , Italy) -

10:30 Pleural effusion in ARDS patients Davide Chiumello ( Milan , Italy) -

10:45 Discussion

11:00 Break

Prognosis after cardiac arrest (RT) [Round table]



Niklas Nielsen ( Helsingborg, Sweden) -11:20 Prognosis after cardiac arrest

Raimund Helbok ( Innsbruck , Austria) -

Jerry Nolan ( Bath , United Kingdom) -

Mauro Oddo ( Lausanne , Switzerland) -

Fabio S Taccone ( Brussels , Belgium) -

Extracorporeal gas exchange [Standard presentation] Niall Ferguson ( Toronto , Canada) - Kai Zacharowski (Frankfurt , Germany) -

13:45 Different techniques for different goals Antonio Pesenti ( Milan , Italy) -

14:00 Extracorporeal CO2 removal Roberto Roncon de Albuquerque ( Porto, Portugal) -

14:15 Low-flow CO2 removal in COPD Nicholas Barrett ( London , United Kingdom) -

14:30 Discussion

14:45 Extracorporeal support and spontaneous breathing Luciano Gattinoni ( Milan , Italy) -

15:00 ECMO for severe acute respiratory failure Simon Finney ( London , United Kingdom) -

15:15 For all patients?Salvatore Grasso ( Bari , Italy) -

15:30 Bridge to lung transplant Giorgio A Iotti ( Pavia , Italy) -

15:45 Discussion

16:00 Expert centers or everywhere? Michael Quintel ( Göttingen , Germany) -

16:15 When and how to wean from ECMO Alain Combes ( Paris , France) -

16:30 A trial of venovenous ECMO for pneumonia is ethical

16:45 A trial of venovenous ECMO for pneumonia is not ethicalDavid Tuxen ( Melbourne , Australia) -

17:00 Discussion

Metabolic support in burns (Tu) [Tutorial] 17:15 Metabolic support in burns

Mette M Berger ( Lausanne , Switzerland) -

Copper HallHemodynamic monitoring [Standard presentation] Peter Radermacher ( Ulm , Germany) - Andrew Rhodes (London , United Kingdom) -

8:00 Review of the different systems Xavier Monnet ( Le Kremlin-Bicêtre , France) -

8:15 Transpulmonary thermodilution Nicholas Kiefer ( Bonn , Germany) -

8:30 Thermodilution-derived variablesJean-Louis Teboul ( Le Kremlin-Bicêtre , France) -

8:45 Pitfalls in the measurement of cardiac output Azriel Perel ( Tel Aviv , Israel) -

9:00 Advanced hemodynamic monitoring Gernot Marx ( Aachen , Germany) -

9:15 Assessing diastolic dysfunction Michel Slama ( Amiens , France) -



9:30 Discussion

9:45 The future of echocardiography Jan Poelaert ( Brussels , Belgium) -

10:00 Widening patient access to flow monitoringMax Jonas ( Southampton , United Kingdom) -

10:15 Non-invasive hemodynamic profiling in the EDRichard M Nowak ( Detroit , United States) -

10:30 The future is entirely non-invasive Charles Phillips ( Portland , United States) -

10:45 No, it is not Jukka Takala ( Bern , Switzerland) -

11:00 Discussion

11:15 Break

Empiric antibiotic therapy for sepsis (Tu) [Tutorial] 11:35 Empiric antibiotic therapy for sepsis

Thierry Calandra ( Lausanne , Switzerland) -

Microcirculatory damage [Standard presentation] Anders Perner ( Copenhagen , Denmark) - Christian J Wiedermann ( Bolzano , Italy) -

13:45 Glycocalyx damage during sepsis Markus Rehm ( Munich , Germany) -

14:00 Microcirculatory alterations: Time matters! Daniel De Backer ( Brussels , Belgium) -

14:15 Role of ROS in microvascular regulation Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

14:30 Role of adenosine Holger K Eltzschig ( Aurora, United States) -

14:45 Can induced hyperpulsatility improve the microcirculation? Didier Payen ( Paris , France) -

15:00 Discussion

15:15 Break

Clinical aspects of the microcirculation [Standard presentation]

Markus Rehm ( Munich , Germany) - Jean-Louis Teboul ( LeKremlin-Bicêtre, France) -

15:35 New technological advances Can Ince ( Amsterdam , Netherlands) -

15:50 In sepsis Daniel De Backer ( Brussels , Belgium) -

16:05 After surgery Rupert Pearse ( London , United Kingdom) -

16:20 Discussion

16:30 After cardiac arrest Katia Donadello ( Brussels , Belgium) -

16:45 In hemorrhagic shock Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

17:00 Why should we bother? Jan Bakker ( Rotterdam , Netherlands) -

17:15 Discussion

Pressure-targeted ventilation (Tu) [Tutorial] 17:25 Pressure-targeted ventilation

Laurent Brochard ( Geneva , Switzerland) -



Salle M (Bozar)The comatose patient [Standard presentation] Mikael Mazighi ( Paris, France) - Nino Stocchetti ( Milan ,Italy) -

8:00 Biology of coma and emergence Robert Stevens ( Baltimore , United States) -

8:15 Hepatic coma Julia Wendon ( London , United Kingdom) -

8:30 Septic encephalopathy Figen Esen ( Istanbul , Turkey) -

8:45 Who will eventually wake up? Steven Laureys ( Liège , Belgium) -

9:00 Discussion

9:15 Break

Therapeutic hypothermia [Standard presentation] Hans Friberg ( Lund , Sweden) - Marek Mirski ( Baltimore ,United States) -

9:40 Protective mechanisms Michael Bell ( Pittsburgh, United States) -

9:55 Defining the target temperature Niklas Nielsen ( Helsingborg, Sweden) -

10:10 How to cool patients Kees Polderman ( Pittsburgh , United States) -

10:25 Hemodynamic management Karim Bendjelid ( Geneva , Switzerland) -

10:40 Discussion

10:55 Effects on the microcirculation Fabio S Taccone ( Brussels , Belgium) -

11:10 Effects on the lung Nicole Juffermans ( Amsterdam , Netherlands) -

11:25 Good for the brain… also good for the heart? Kjetil Sunde ( Oslo , Norway) -

11:40 Also in severe trauma?Samuel Tisherman ( Pittsburgh, United States) -

11:55 Discussion

Stroke [Standard presentation] Raimund Helbok ( Innsbruck , Austria) - Marek Mirski (Baltimore , United States) -

13:45 Emergency management of intracerebral hemorrhage Joshua N Goldstein ( Boston, United States) -

14:00 ICU management of intracerebral hemorrhage Paul Vespa ( Los Angeles , United States) -

14:15 Endovascular therapy in severe cases Didier Payen ( Paris , France) -

14:30 Discussion

14:45 Complications of endovascular therapy Mikael Mazighi ( Paris, France) -

15:00 Reperfusion strategies: Thrombolysis or clot removal? Robert Stevens ( Baltimore , United States) -

15:15 Neuroprotection: Clinical aspects Terence Valenzuela ( Tucson, United States) -



15:30 Discussion

15:45 Break

Subarachnoid hemorrhage [Standard presentation] Stephane Legriel ( Le Chesnay, France) - Andrew I Maas (Edegem , Belgium) -

16:15 Critical care management Giuseppe Citerio ( Monza , Italy) -

16:30 The role of the lectin pathway Elisa R Zanier ( Milan, Italy) -

16:45 Global cerebral edema after SAH: An understudied entity? Raimund Helbok ( Innsbruck , Austria) -

17:00 Discussion

17:15 When to transfuse Peter Le Roux ( Philadelphia, United States) -

17:30 Management of vasospasm Paul Vespa ( Los Angeles , United States) -

17:45 Discussion

TentRenal dysfunction [Standard presentation] Rinaldo Bellomo ( Melbourne, Australia) - Martin Matejovic (Plzen , Czech Republic) -

8:00 The changing epidemiology: Results from an international registry Ravindra Mehta ( San Diego , United States) -

8:15 Pediatric research in renal failure: How it can benefit all populations Stuart Goldstein ( Cincinnati , United States) -

8:30 Contrast-induced renal failure Eric Hoste ( Ghent , Belgium) -

8:45 Is this a problem in the ICU patient?Daniel H Kett ( Miami , United States) -

9:00 Discussion

9:15 Outcomes from acute kidney injury not treated by RRT Sean Bagshaw ( Edmonton , Canada) -

9:30 Doppler ultrasonography Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

9:45 GFR determinations and plasma volume determinations at the bedsideBruce A Molitoris ( Indianapolis , United States) -

10:00 Long-term outcomes Max Bell ( Stockholm, Sweden) -

10:15 Discussion

How much fluid? [Standard presentation] Per-Olof Grände ( Lund , Sweden) - John Prowle ( London,United Kingdom) -

10:30 Beyond the Frank-Starling mechanism Jan Bakker ( Rotterdam , Netherlands) -

10:45 Impact on inflammation and tissue oxygenation Can Ince ( Amsterdam , Netherlands) -

11:00 How much is too much: The holy grail of optimal fluid management Berthold Bein ( Kiel , Germany) -

11:15 Renal and splenic Doppler to evaluate fluid status Paolo Pelosi ( Genoa , Italy) -

11:30 Timing of fluid resuscitation in septic shock Greg S Martin ( Atlanta , United States) -



11:45 Perioperative hemodynamic goal-directed therapy Christa Boer ( Amsterdam , Netherlands) -

12:00 Discussion

Cardiac failure [Standard presentation] Karim Bendjelid ( Geneva , Switzerland) - Xavier Monnet ( LeKremlin-Bicêtre , France) -

13:45 Inflammation in cardiovascular disease Dan Longrois ( Paris , France) -

14:00 Understanding the pathophysiology Fabio Guarracino ( Pisa , Italy) -

14:15 Diastolic heart failure Zoltan Papp ( Debrecen, Hungary) -

14:30 Utility of biomarkersSalvatore Di Somma ( Rome , Italy) -

14:45 Altered cardiac function in septic shock Michel Slama ( Amiens , France) -

15:00 Hepatic dysfunction: Decreased blood flow or high CVP? Alexandre Mebazaa ( Paris , France) -

15:15 Discussion

15:30 Neurocardiac interactions in acute heart failure Anthony McLean ( Sydney , Australia) -

15:45 Atrial fibrillation in the ICU Jonathan Ball ( London , United Kingdom) -

16:00 Levosimendan: Just for hemodynamic improvement? Zoltan Papp ( Debrecen, Hungary) -

16:15 Still a place for aortic balloon counterpulsation? Karl Werdan ( Halle , Germany) -

16:30 Transcatheter interventions on diseased heart valves Fabio Guarracino ( Pisa , Italy) -

16:45 Discussion

Fluids vs diuretics: How to decide ? [Standard presentation] Azriel Perel ( Tel Aviv , Israel) - Antoine Vieillard-Baron (Boulogne-Billancourt , France) -

17:00 Is urine output a reliable marker of acute kidney injury? Matthieu Legrand ( Paris , France) -

17:15 Fluid overload is a more important marker than creatinine Stuart Goldstein ( Cincinnati , United States) -

17:30 We should use fewer diuretics in acute heart failure Etienne Gayat ( Paris, France) -

17:45 Discussion

Silver HallSafer intubation [Standard presentation] Marcelo Amato ( Sao Paulo , Brazil) - Paolo Pelosi ( Genoa ,Italy) -

8:00 Airway management during CPR Jerry Nolan ( Bath , United Kingdom) -

8:15 Preoxygenation and intubation revisited Samir Jaber ( Montpellier , France) -

8:30 Still a place for etomidate? Dan Longrois ( Paris , France) -

8:45 Novel video laryngoscopes John G Laffey ( Toronto, Canada) -



9:00 Discussion

9:15 Video laryngoscopy with reduced sedation Paul H Mayo ( New York , United States) -

9:30 ETCO2 monitoring reviewedMassimo Antonelli ( Rome , Italy) -

9:45 Novel ET tubes Lorenzo Berra ( Boston, United States) -

10:00 Discussion

10:15 Break

Has VAP gone? [Standard presentation] Lorenzo Berra ( Boston, United States) - Jean Chastre ( Paris ,France) -

10:35 New CDC definitions Marcos Restrepo ( San Antonio , United States) -

10:50 Do these represent a real progress?Michael S Niederman ( Mineola , United States) -

11:05 Surveillance of ventilator-associated events Robert M Kacmarek ( Boston , United States) -

11:20 Discussion

11:30 Markers in bronchoalveolar lavage: Do they help? Antonio Pesenti ( Milan , Italy) -

11:45 Update on managementMichael S Niederman ( Mineola , United States) -

12:00 Discussion

Renal biomarkers [Standard presentation] Bruce A Molitoris ( Indianapolis , United States) - Miet Schetz (Leuven , Belgium) -

13:45 Directive assessment for your favorite kidney troponin Stuart Goldstein ( Cincinnati , United States) -

13:55 Subclinical renal impairment Claudio Ronco ( Vicenza , Italy) -

14:05 Novel biomarkers of injury Rinaldo Bellomo ( Melbourne, Australia) -

14:15 We need physiological biomarkers Can Ince ( Amsterdam , Netherlands) -

14:25 Discussion

14:35 New cell-cycle arrest biomarkers John Kellum ( Pittsburgh , United States) -

14:50 What’s wrong with these new biomarkers ? Matthieu Legrand ( Paris , France) -

15:00 We need to combine functional and injury biomarkers Ravindra Mehta ( San Diego , United States) -

15:10 Applying all this to clinical practice John Prowle ( London, United Kingdom) -

15:20 Discussion

15:35 Break

Emerging molecular biology [Standard presentation] Jean Chastre ( Paris , France) - Alan S Maisel ( San Diego,United States) -

15:50 Omics for dummies



Jean-Daniel Chiche ( Paris , France) -

16:05 Early recognition of pathogens Steven Opal ( Providence , United States) -

16:20 MicroRNA as a tool in the ICU Anthony McLean ( Sydney , Australia) -

16:35 MicroRNAs in sepsis Roberto Roncon de Albuquerque ( Porto, Portugal) -

16:50 Discussion

17:00 Techniques for genotyping Jean-Paul Mira ( Paris , France) -

17:15 Genotyping in acute inflammation Didier Payen ( Paris , France) -

17:30 Targeting the epigenomeSteven Opal ( Providence , United States) -

17:45 Discussion

100 HallCPR [Standard presentation] Fabio Guarracino ( Pisa , Italy) - Zoltan Papp ( Debrecen,Hungary) -

8:00 Past, present, and future Raymond L Fowler ( Dallas , United States) -

8:15 No ventilation CPR Paul E Pepe ( Dallas , United States) -

8:30 Should end-tidal CO2 be used routinely? Kjetil Sunde ( Oslo , Norway) -

8:45 Mechanical devices for cardiac massage: Must-have or luxury?Giuseppe Biondi-Zoccai ( Rome, Italy) -

9:00 Discussion

9:15 Still a role for epinephrine in CPR? Jerry Nolan ( Bath , United Kingdom) -

9:30 Future tool-kits in cardiac arrest Paul E Pepe ( Dallas , United States) -

9:45 When to use ECMO Alain Combes ( Paris , France) -

10:00 Is it worth the effort? Daniel De Backer ( Brussels , Belgium) -

10:15 Discussion

10:30 Break

New Antibiotics (Pl) [Plenary lecture] 10:50 New antibiotics

Tobias Welte ( Hannover , Germany) -

Ethical problems for military doctors: Detainees, torture (pl) [Plenary lecture]

11:15 Ethical problems for military doctors and why intensivists should be interestedMichael Reade ( Herston QLD, Australia) -

Is CVP dead? [Pro-con debate] Johan Groeneveld ( Rotterdam, Netherlands) -

11:40 Is CVP dead?PRO : Daniel Reuter ( Hamburg , Germany) -

CON :

Cardiorespiratory monitoring [Standard presentation] Samir Jaber ( Montpellier , France) - Neil R MacIntyre (Durham , United States) -



13:45 Basic monitoring: The neglected essentials Berthold Bein ( Kiel , Germany) -

14:00 Ultrasound monitoring during ventilation Armand Mekontso Dessap ( Créteil , France) -

14:15 The chest radiograph is obsolete in the ICU Paul H Mayo ( New York , United States) -

14:30 Ventilation monitoring using electrical impedance tomography Inez Frerichs ( Kiel , Germany) -

14:45 Discussion

14:55 Ventilator waveforms for upper vs lower airway obstruction David Tuxen ( Melbourne , Australia) -

15:10 Monitoring work of breathing by diaphragm electromyography Antonio Pesenti ( Milan , Italy) -

15:25 Monitoring work of breathing during partial ventilatory support Giuseppe Foti ( Lecco, Italy) -

15:40 Discussion

15:50 Break

16:10 Role of extravascular lung water measurements Manu Malbrain ( Antwerp , Belgium) -

16:25 Electrical impedance tomography for hemodynamic assessment Daniel Reuter ( Hamburg , Germany) -

16:40 New non-invasive tools to evaluate left ventricular mechanics Etienne Gayat ( Paris, France) -

16:55 Brains and breathing: Why do not we monitor both?Michael Ramsay ( Dallas , United States) -

17:10 Monitoring tissue oxygenation Mervyn Singer ( London , United Kingdom) -

17:25 Discussion

How to minimize sedation (Tu) [Tutorial] 17:40 How to minimize sedation

Thomas Strom ( Copenhagen, Denmark) -

400 HallImmunomodulation [Standard presentation] Jean-Marc Cavaillon ( Paris , France) - Konrad Reinhart ( Jena, Germany) -

8:00 Sepsis-induced immunosuppression Didier Payen ( Paris , France) -

8:15 We need immuno-monitoring in sepsis Jean-Daniel Chiche ( Paris , France) -

8:30 Aspergillosis in the acutely ill Thierry Calandra ( Lausanne , Switzerland) -

8:45 CMV reactivation: To treat or not to treat? Gordon Rubenfeld ( Toronto , Canada) -

9:00 Herpes viridae infections in ICU patients: To treat or not to treat? Laurent Papazian ( Marseille , France) -

9:15 Discussion

My dream therapy [Standard presentation] John Kellum ( Pittsburgh , United States) - Claude Martin (Marseille , France) -

9:30 Vanadium for a renal hit Jan Bakker ( Rotterdam , Netherlands) -



9:45 Protease-activated receptors in pneumonia Tom van der Poll ( Amsterdam , Netherlands) -

10:00 CD28 antagonists in sepsisSteven Opal ( Providence , United States) -

10:15 Discussion

10:25 Oxygen carriers in hemorrhagic shock Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

10:40 Adenosine for ischemia-reperfusion Holger K Eltzschig ( Aurora, United States) -

10:55 Nitroprusside in CPR Paul E Pepe ( Dallas , United States) -

11:10 Discussion

11:20 New neuroprotective strategies Alan I Faden ( Baltimore, United States) -

11:35 Stem cells for acute brain injury Elisa R Zanier ( Milan, Italy) -

11:50 Activated protein C for lung injury Tom van der Poll ( Amsterdam , Netherlands) -

12:05 Discussion

After cardiac arrest [Standard presentation] Nicole Juffermans ( Amsterdam , Netherlands) - Kees Polderman ( Pittsburgh , United States) -

13:45 Emergency coronary angiography for all?Giuseppe Biondi-Zoccai ( Rome, Italy) -

14:00 The post-cardiac arrest syndrome Jerry Nolan ( Bath , United Kingdom) -

14:15 Does cardiac arrest lead to renal failure? Ravindra Mehta ( San Diego , United States) -

14:30 Discussion

14:40 Is hyperoxia really bad? Evert De Jonge ( Leiden , Netherlands) -

14:55 Carbon dioxide: A new target Rinaldo Bellomo ( Melbourne, Australia) -

15:10 Glucose control Fabio S Taccone ( Brussels , Belgium) -

15:25 PrognosisMauro Oddo ( Lausanne , Switzerland) -

15:40 Simplified EEG/aEEG to monitor the injured brain Hans Friberg ( Lund , Sweden) -

15:55 Discussion

16:05 Neuroimaging to predict outcome Robert Stevens ( Baltimore , United States) -

16:20 Biomarkers for hypoxic brain injuryMichael Joannidis ( Innsbruck , Austria) -

16:35 What questions remain? Niklas Nielsen ( Helsingborg, Sweden) -

16:50 Discussion

17:00 Break

Therapeutic hypothermia after cardiac arrest: Practical



application (Tu) [Tutorial] 17:20 Therapeutic hypothermia after cardiac arrest: Practical application

Jerry Nolan ( Bath , United Kingdom) -

Studio (Bozar)Improving communication [Standard presentation] Elie Azoulay ( Paris , France) - Hannah Wunsch ( New York ,United States) -

8:00 Communication tools and toys in the ICU Khalid Shukri ( Kuwait City, Kuwait) -

8:15 Improving ward rounds Balasubramanian Venkatesh ( Brisbane , Australia) -

8:30 Improving hand-overs Daniel Reuter ( Hamburg , Germany) -

8:45 Discussion

9:00 Electronic alerts in the ICU: Do they help? Johan Decruyenaere ( Ghent , Belgium) -

9:15 Surgical strategies: When do you call me?Peter Le Roux ( Philadelphia, United States) -

9:30 Improving teamwork by simulation Luca Cabrini ( Milan , Italy) -

9:45 Discussion

10:00 Break

Patients and families [Standard presentation] Marcus Schultz ( Amsterdam , Netherlands) - Thomas Strom (Copenhagen, Denmark) -

10:20 Behavioral economics of intensive care Derek C Angus ( Pittsburgh , United States) -

10:35 Family satisfaction Simon Finney ( London , United Kingdom) -

10:50 Conflicts with relatives Elie Azoulay ( Paris , France) -

11:05 Collateral damage: The impact of critical illness on the families of survivors Michael Pinsky ( Pittsburgh , United States) -

11:20 Discussion

Status epilepticus (Tu) [Tutorial] 11:35 Status epilepticus

Stephane Legriel ( Le Chesnay, France) -

Organization: Process of care [Standard presentation] Bertrand Guidet ( Paris , France) - Gordon Rubenfeld ( Toronto, Canada) -

13:45 Role of ICU organization on patient outcomes Greg S Martin ( Atlanta , United States) -

14:00 Volume-outcome relationshipsJeremy M Kahn ( Pittsburgh , United States) -

14:15 Transitioning the child to an adult ICU Joe Brierley ( London, United Kingdom) -

14:30 Discussion

14:40 The postoperative geriatric care unit Bruno Riou ( Paris , France) -

14:55 Can we afford an open ICU model with limited resources? Massimo Antonelli ( Rome , Italy) -

15:10 The role of nighttime intensivists Jeremy M Kahn ( Pittsburgh , United States) -



15:25 Do we really need intensivists?Scott D Halpern ( Philadelphia, United States) -

15:40 Discussion

15:50 Tele-ICU: Tool or toy Gernot Marx ( Aachen , Germany) -

16:05 My experience with telemedicine in the ICU Paul Vespa ( Los Angeles , United States) -

16:20 Optimizing recovery in the post-ICU period Timothy Walsh ( Edinburgh , United Kingdom) -

16:35 Discussion

Critical care in the field [Standard presentation] Eric Maury ( Paris , France) - Sven-Erik Ricksten ( Gothenburg,Sweden) -

16:45 Mobile critical care Michael Reade ( Herston QLD, Australia) -

17:00 Mechanical ventilation at altitudeRichard Branson ( Cincinatti , United States) -

17:15 Blast lung treatment Jeremy Henning ( Birmingham, United Kingdom) -

17:30 Mass events Paul E Pepe ( Dallas , United States) -

17:45 Discussion

Horta RoomPatient-ventilator synchrony (Tu) [Tutorial]

8:00 Patient-ventilator synchrony Robert M Kacmarek ( Boston , United States) -

Subarachnoid hemorrhage guidelines (Tu) [Tutorial] 8:40 Subarachnoid hemorrhage guidelines

Paul Vespa ( Los Angeles , United States) -

Coronary syndromes (Pl) [Plenary lecture] 9:20 Coronary syndromes

Giuseppe Biondi-Zoccai ( Rome, Italy) -

Antimicrobial stewardship: Opportunities and challenges (Tu) [Tutorial]

9:50 Antimicrobial stewardship: Opportunities and challenges David P Nicolau ( Hartford , United States) -

Right heart failure [Standard presentation] Etienne Gayat ( Paris, France) - Bruno Riou ( Paris , France) -

10:30 Due to myocardial failure Alexandre Mebazaa ( Paris , France) -

10:45 During mechanical ventilation Antoine Vieillard-Baron ( Boulogne-Billancourt , France) -

11:00 In severe pulmonary embolism Anthony McLean ( Sydney , Australia) -

11:15 In the postoperative patient Sven-Erik Ricksten ( Gothenburg, Sweden) -

11:30 Discussion

Basic understanding of lung mechanics for pediatric ventilation(Tu) [Tutorial]

11:45 Basic understanding of lung mechanics for pediatric ventilation Peter Rimensberger ( Geneva , Switzerland) -

How we react to tissue injury [Standard presentation] Derek C Angus ( Pittsburgh , United States) - Claude Martin (Marseille , France) -

13:45 The acute stress response Mervyn Singer ( London , United Kingdom) -



14:00 Autonomic dysfunction in critical illness Gareth Ackland ( London , United Kingdom) -

14:15 How does the host recognize danger? John C Marshall ( Toronto , Canada) -

14:30 Discussion

14:40 The innate response Thierry Calandra ( Lausanne , Switzerland) -

14:55 Is the response to infection so specific? Tom van der Poll ( Amsterdam , Netherlands) -

15:10 What role for apoptosisRaquel Herrero ( Madrid, Spain) -

15:25 How age alters this Karl Werdan ( Halle , Germany) -

15:40 Discussion

15:50 The hidden factors influencing the host response Jean-Marc Cavaillon ( Paris , France) -

16:05 How liver dysfunction alters this Julia Wendon ( London , United Kingdom) -

16:20 Oxidative stress: Is it worth the stress of thinking about it? Steffen Rex ( Leuven, Belgium) -

16:35 The hypoxia-inflammation link Holger K Eltzschig ( Aurora, United States) -

16:50 Discussion

17:00 Carbonyl stress in sepsis: Friend or foe? Stefan Hofer ( Heidelberg , Germany) -

17:15 Endotoxin plays an important role John C Marshall ( Toronto , Canada) -

17:30 Endotoxin is not a central player in the pathophysiology of sepsis Hiroyuki Hirasawa ( Chiba , Japan) -

17:45 Discussion

3/21/2013Gold Hall

SSC guidelines [Standard presentation] Jeremy M Kahn ( Pittsburgh , United States) -William Manzanares ( Montevideo, Uruguay) -

8:00 Surviving the new SSC Guidelines Gordon Rubenfeld ( Toronto , Canada) -

8:15 Should we use the SSC guidelines for hemodynamic resuscitation in septicshock? YesDerek C Angus ( Pittsburgh , United States) -

8:25 Should we use the SSC guidelines for hemodynamic resuscitation in septicshock? NoJean-Louis Teboul ( Le Kremlin-Bicêtre , France) -

8:35 Optimizing the emergency department/ICU interface Eddy Lang ( Calgary, Canada) -

8:50 Discussion

9:00 Resuscitation of shock: Art versus algorithm? Charles Phillips ( Portland , United States) -

9:15 Resuscitation from severe sepsis: Do we need care bundles? YesArthur Van Zanten ( Ede , Netherlands) -

9:25 Resuscitation from severe sepsis: Do we need care bundles? No



Azriel Perel ( Tel Aviv , Israel) -

9:35 Discussion

9:50 Poster awardsJukka Takala ( Bern , Switzerland) -

Hemodynamic resuscitation in sepsis [Standard presentation] Djillali Annane ( Garches , France) - Jan Bakker ( Rotterdam ,Netherlands) -

10:00 Temporal trends in the epidemiology of sepsis Greg S Martin ( Atlanta , United States) -

10:15 Sepsis in cirrhosisThierry Gustot ( Brussels, Belgium) -

10:30 What are we trying to correct? Fabio Guarracino ( Pisa , Italy) -

10:45 Echocardiography to guide management Anthony McLean ( Sydney , Australia) -

11:00 Continuous echocardiography : A novel approach Jukka Takala ( Bern , Switzerland) -

11:15 Discussion

11:30 Fluid resuscitation in children: What does the FEAST trial tell us? Matthew Bacchetta ( New York, United States) -

11:45 So, how much fluid in pediatric sepsis? Joe Brierley ( London, United Kingdom) -

12:00 Blood transfusions are needed for septic patientsCan Ince ( Amsterdam , Netherlands) -

12:15 Fluid therapy in septic acute kidney injury: Too much, too little or just right? John Prowle ( London, United Kingdom) -

12:30 Discussion

Types of fluid: The basics [Standard presentation] David Gattas ( Sydney , Australia) - Michael Joannidis (Innsbruck , Austria) -

13:30 The basic characteristics of i.v. fluids Markus Rehm ( Munich , Germany) -

13:45 Colloids vs crystalloids: A physiological approach Per-Olof Grände ( Lund , Sweden) -

14:00 Colloids improve the microcirculation Zsolt Molnar ( Szeged , Hungary) -

14:15 Discussion

14:30 High viscosity fluids: Good or bad? Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

14:45 Albumin: Review of its function and kinetics Jan Wernerman ( Stockholm , Sweden) -

15:00 How does HES accumulate in the tissues? Christian J Wiedermann ( Bolzano , Italy) -

15:15 Discussion

15:30 How can HES induce renal injury? Gernot Marx ( Aachen , Germany) -

15:45 How can HES induce coagulopathy? Anders Perner ( Copenhagen , Denmark) -

16:00 HES can have protective effects Paolo Pelosi ( Genoa , Italy) -



16:15 Discussion

16:30 Break

Beta-stimulation or blockade? [Standard presentation] Figen Esen ( Istanbul , Turkey) - Rupert Pearse ( London ,United Kingdom) -

16:50 The harmful effects of catecholamines Mervyn Singer ( London , United Kingdom) -

17:05 Beta-blocking agents Djillali Annane ( Garches , France) -

17:20 Beta-blocking agents in neurological patients Nino Stocchetti ( Milan , Italy) -

17:35 Beta-blocking agents in head traumaKees Polderman ( Pittsburgh , United States) -

17:50 Discussion

Copper HallFluids: When to start, when to stop? [Standard presentation]

8:00 Bedside examination Jukka Takala ( Bern , Switzerland) -

8:15 Assessing the kidney response Johan Groeneveld ( Rotterdam, Netherlands) -

8:30 What is fluid responsiveness? Xavier Monnet ( Le Kremlin-Bicêtre , France) -

8:45 How it is applied in the USCharles S Brudney ( Durham , United States) -

9:00 Limits of functional hemodynamic monitoring Michael Pinsky ( Pittsburgh , United States) -

9:15 Discussion

9:30 Assessing fluid responsiveness Paul E Marik ( Norfolk , United States) -

9:45 Does it equal need for fluids? Michael Pinsky ( Pittsburgh , United States) -

10:00 Also in children? Joe Brierley ( London, United Kingdom) -

10:15 How much fluid in traumatic shock?Samuel Tisherman ( Pittsburgh, United States) -

10:30 Discussion

10:45 Functional hemodynamics in high-risk surgical cases Azriel Perel ( Tel Aviv , Israel) -

11:00 Assessment of volume responsiveness in spontaneously breathing patients Xavier Monnet ( Le Kremlin-Bicêtre , France) -

11:15 How to assess fluid needs using echocardiography Michel Slama ( Amiens , France) -

11:30 Discussion

Renal function (Tu) [Tutorial] 11:45 Renal function

Bruce A Molitoris ( Indianapolis , United States) -

Mechanical ventilation in ARDS [Standard presentation] Laurent Brochard ( Geneva , Switzerland) - Luciano Gattinoni (Milan , Italy) -

13:45 An RV protective approach Antoine Vieillard-Baron ( Boulogne-Billancourt , France) -

14:00 The importance of driving pressure Marcelo Amato ( Sao Paulo , Brazil) -

14:15 How muscle relaxants can improve ARDS prognosis? Laurent Papazian ( Marseille , France) -

14:30 Role of hypercapnia in protective lung ventilation strategies John G Laffey ( Toronto, Canada) -



14:45 The dark side of spontaneous ventilation: Overstretch of sub-diaphragmaticlung regions Marcelo Amato ( Sao Paulo , Brazil) -

15:00 Discussion

15:15 Spontaneous ventilation for ARDS: ProPaolo Pelosi ( Genoa , Italy) -

15:30 Spontaneous ventilation for ARDS: ConJohn J Marini ( St Paul , United States) -

15:45 Spontaneous ventilation for ARDS: MaybeAntonio Pesenti ( Milan , Italy) -

16:00 Biopsy or bronchoalveolar lavage to assess fibrosis in ARDS patients? Laurent Papazian ( Marseille , France) -

16:15 Discussion

16:30 Break

VAP: Preventive measures [Standard presentation] Daniel H Kett ( Miami , United States) - Michael S Niederman (Mineola , United States) -

17:00 Prevention of VAP: New endotracheal tube technologies Marcos Restrepo ( San Antonio , United States) -

17:15 Novel medical devices in respiratory care Lorenzo Berra ( Boston, United States) -

17:30 VAP: Best practice for diagnosis and prevention Timothy Walsh ( Edinburgh , United Kingdom) -

17:45 Discussion

Salle M (Bozar)Protecting the lungs [Standard presentation] Alain Combes ( Paris , France) - Robert M Kacmarek ( Boston ,United States) -

8:00 For everyone? Marcus Schultz ( Amsterdam , Netherlands) -

8:15 What’s the ideal tidal volume? Simon Finney ( London , United Kingdom) -

8:30 Volume is more important than pressure Diederik Gommers ( Rotterdam , Netherlands) -

8:45 Discussion

9:00 Pressure is more important than volume Niall Ferguson ( Toronto , Canada) -

9:15 Moderately high-frequency ventilation Marcelo Amato ( Sao Paulo , Brazil) -

9:30 Stress index Marco Ranieri ( Turin , Italy) -

9:45 Discussion

10:00 Co-factors that determine VILI John J Marini ( St Paul , United States) -

10:15 NAVA as a lung protective strategy in ARDSArthur S Slutsky ( Toronto , Canada) -

10:30 Lung recruitment: Safety, physiology and clinical benefits Marcelo Amato ( Sao Paulo , Brazil) -

10:45 Applications in children Matthew Bacchetta ( New York, United States) -

11:00 Closed loop control of oxygenation



Richard Branson ( Cincinatti , United States) -

11:15 Discussion

11:30 Break

Synthetic colloids should be abandoned [Pro-con debate] Paul H Mayo ( New York , United States) -

11:45 Synthetic colloids should be abandoned PRO : John Myburgh ( Sydney, Australia) -

CON : Philippe Van Der Linden ( Brussels , Belgium) -

A new look at vasopressin [Standard presentation] Eddy Lang ( Calgary, Canada) - Greg S Martin ( Atlanta , UnitedStates) -

13:45 Vasopressin in hepatorenal syndromesSean Bagshaw ( Edmonton , Canada) -

14:00 A rationale for vasopressin administration in sepsis Peter Radermacher ( Ulm , Germany) -

14:15 Effects of vasopressin on regional blood flow Rinaldo Bellomo ( Melbourne, Australia) -

14:30 Discussion

14:45 Interactions between vasopressin and steroids Anthony Gordon ( London , United Kingdom) -

15:00 Selepressin in experimental sepsis Fuhong Su ( Brussels , Belgium) -

15:15 Selepressin in patients with septic shock Jean-Louis Vincent ( Brussels , Belgium) -

15:30 Discussion

15:45 Break

Liver failure [Standard presentation] Jeremy Henning ( Birmingham, United Kingdom) - Ashita Tolwani( Birmingham, United States) -

16:10 How does ‘acute’ differ from ‘acute-on-chronic’ liver failure Julia Wendon ( London , United Kingdom) -

16:35 Organ dysfunction in the cirrhotic patient: Lung, heart and kidney Pierre-François Laterre ( Brussels , Belgium) -

16:50 Discussion

17:00 How to provide sedation and analgesia in these patientsMichael Ramsay ( Dallas , United States) -

17:15 Management of severe alcoholic hepatitis Thierry Gustot ( Brussels, Belgium) -

17:30 When to transplant Julia Wendon ( London , United Kingdom) -

17:45 Discussion

TentAntibiotic strategies [Standard presentation] Matteo Bassetti ( Udine, Italy) - Roberto Roncon deAlbuquerque ( Porto, Portugal) -

8:00 Optimal antibiotic treatment in the ICU Claude Martin ( Marseille , France) -

8:15 Combination antibiotic therapy for severe infection Tobias Welte ( Hannover , Germany) -

8:30 Procalcitonin for antibiotic stewardship: Is there enough evidence? Beat Müller ( Aarau , Switzerland) -

8:45 How the duration of antibiotic therapy can influence outcome in VAP



Marin Kollef ( St Louis , United States) -

9:00 Discussion

9:15 How to optimize dosing Fabio S Taccone ( Brussels , Belgium) -

9:30 The place of inhaled antibiotics David P Nicolau ( Hartford , United States) -

9:45 Aerosolized antibiotics: Are they ready to treat VAP? Jean Chastre ( Paris , France) -

10:00 Discussion

Hemodynamic aspects of respiratory failure [Standardpresentation] Berthold Bein ( Kiel , Germany) - Johan Groeneveld (Rotterdam, Netherlands) -

10:15 Pulmonary vascular dysfunction during ARDS Armand Mekontso Dessap ( Créteil , France) -

10:30 Monitoring pulmonary artery pressure is important Antonio Pesenti ( Milan , Italy) -

10:45 RV dysfunction vs failureAntoine Vieillard-Baron ( Boulogne-Billancourt , France) -

11:00 Discussion

11:15 Coping with the hemodynamic effects of PEEP Jean-Daniel Chiche ( Paris , France) -

11:30 Effects on right ventricular afterload: PEEP vs tidal volume Diederik Gommers ( Rotterdam , Netherlands) -

11:45 Pulmonary-renal interactions: What to consider? Michael Joannidis ( Innsbruck , Austria) -

12:00 Discussion

Energy requirements: How early and how much? [Standardpresentation] Robert Sanders ( London , United Kingdom) - Jukka Takala (Bern , Switzerland) -

13:45 Metabolic syndrome in critical illnessBalasubramanian Venkatesh ( Brisbane , Australia) -

14:00 Malnutrition: An emergency in your ICU?Paul Wischmeyer ( Aurora , United States) -

14:15 The role of autophagy in critical illness Greet Van Den Berghe ( Leuven , Belgium) -

14:30 What influences oxygen demand? Mervyn Singer ( London , United Kingdom) -

14:45 Discussion

14:55 Computers are needed to optimize nutritional therapy Mette M Berger ( Lausanne , Switzerland) -

15:10 How nutrition may influence outcomes in renal failure Rinaldo Bellomo ( Melbourne, Australia) -

15:25 Optimal nutritional support in renal failure (PICARD trial)Ravindra Mehta ( San Diego , United States) -

15:40 Discussion

15:50 Protein intake is more critical than energy Jean-Charles Preiser ( Brussels , Belgium) -

16:05 Optimal protein supplementation of the critically ill Jan Wernerman ( Stockholm , Sweden) -



16:20 My favorite feeding strategy Alexander Wilmer ( Leuven , Belgium) -

16:35 Discussion

Should we regionalize critical care? [Standard presentation] Giuseppe Foti ( Lecco, Italy) - Raymond L Fowler ( Dallas ,United States) -

16:45 Pediatric specialized units? Michael Bell ( Pittsburgh, United States) -

17:00 Cardiac arrest centers? Jerry Nolan ( Bath , United Kingdom) -

17:15 ECMO centers? Nicolo Patroniti ( Monza , Italy) -

17:30 ICUs?Jeremy M Kahn ( Pittsburgh , United States) -

17:45 Discussion

Silver HallPolytrauma [Standard presentation] Michael Ramsay ( Dallas , United States) - Rob Russell (Birmingham, United Kingdom) -

8:00 Hypotensive resuscitation from hemorrhagic shock Samuel Tisherman ( Pittsburgh, United States) -

8:15 Point of care ultrasound in the emergency roomSalvatore Di Somma ( Rome , Italy) -

8:30 How to accelerate transfer to the operating room Giuseppe Foti ( Lecco, Italy) -

8:45 Decision-making in multiple trauma John C Marshall ( Toronto , Canada) -

9:00 Discussion

9:15 Pelvic trauma Thomas Geeraerts ( Toulouse , France) -

9:30 Liver trauma Julia Wendon ( London , United Kingdom) -

9:45 Spinal trauma Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

10:00 New guidelines for massive bleedingJean-Louis Vincent ( Brussels , Belgium) -

10:15 Discussion

10:30 Kidney injury after major trauma John Prowle ( London, United Kingdom) -

10:45 Hemodynamic monitoring: What should we measure? Rupert Pearse ( London , United Kingdom) -

11:00 Serial lactate levels to evaluate the patient’s course Bruno Riou ( Paris , France) -

11:15 Quality indicators in trauma care Michael Reade ( Herston QLD, Australia) -

11:30 Discussion

Basics of respiratory physiology (Tu) [Tutorial] 11:45 Basics of respiratory physiology

John G Laffey ( Toronto, Canada) -

Adjunct therapies in sepsis [Standard presentation] Marin Kollef ( St Louis , United States) - Paul E Marik ( Norfolk, United States) -



13:45 Hypercapnia: Benefit or harm?

14:00 What place for statins? Mervyn Singer ( London , United Kingdom) -

14:15 Corticosteroids for septic shock Djillali Annane ( Garches , France) -

14:30 Discussion

14:45 Do we need another trial on steroids? Balasubramanian Venkatesh ( Brisbane , Australia) -

15:00 What place for glutamine? Richard Griffiths ( Liverpool , United Kingdom) -

15:15 And selenium?Konrad Reinhart ( Jena , Germany) -

15:30 Selenium: A literature reviewWilliam Manzanares ( Montevideo, Uruguay) -

15:45 Discussion

16:00 Break

16:20 Macrolides as immunomodulators Marcos Restrepo ( San Antonio , United States) -

16:35 ImmunoglobulinsZsolt Molnar ( Szeged , Hungary) -

16:50 A place for anti-TLR interventions? Thierry Calandra ( Lausanne , Switzerland) -

17:05 Reversing sepsis-induced immune suppression John Kellum ( Pittsburgh , United States) -

17:20 Discussion

The agitated patient (Pl) [Plenary lecture] 17:35 The agitated patient

Michael Reade ( Herston QLD, Australia) -

100 HallIn the emergency room [Standard presentation] Ken Hillman ( Liverpool , Australia) - Axel Nierhaus ( Hamburg, Germany) -

8:00 Ultrasound for vascular access Eric Maury ( Paris , France) -

8:15 Should CPAP be given to all patients with pulmonary edema? Karim Bendjelid ( Geneva , Switzerland) -

8:30 Acute chest syndrome in sickle cell disease Armand Mekontso Dessap ( Créteil , France) -

8:45 Utility of biomarkersSalvatore Di Somma ( Rome , Italy) -

9:00 Discussion

9:15 Procalcitonin in acutely dyspneic patientsAlan S Maisel ( San Diego, United States) -

9:30 Severe community-acquired pneumonia prediction tools Marcos Restrepo ( San Antonio , United States) -

9:45 Risk stratification from the ER to discharge Beat Müller ( Aarau , Switzerland) -

10:00 Discussion

10:15 High-sensitivity troponin in the ER Eddy Lang ( Calgary, Canada) -



10:30 Prasugrel vs ticagrelor in acute coronary syndromes Giuseppe Biondi-Zoccai ( Rome, Italy) -

10:45 Time to recanalization: A critical goal for stroke therapy Mikael Mazighi ( Paris, France) -

11:00 Accidental hypothermia Kees Polderman ( Pittsburgh , United States) -

11:15 Discussion

Obstructive lung disease [Standard presentation] Michael Quintel ( Göttingen , Germany) - David Tuxen (Melbourne , Australia) -

11:30 Risk stratification in COPD: Beyond lung function Daiana Stolz ( Basel , Switzerland) -

11:45 Airflow obstruction: Lessons learned over 30 years John J Marini ( St Paul , United States) -

12:00 Exacerbation of COPD Tobias Welte ( Hannover , Germany) -

12:15 Acute severe asthma Jonathan Ball ( London , United Kingdom) -

12:30 Changing management and improving outcome Andres Esteban ( Madrid , Spain) -

12:45 Discussion

Weaning [Standard presentation] Richard Branson ( Cincinatti , United States) - Jaume Canet (Barcelona, Spain) -

13:30 How I do it Neil R MacIntyre ( Durham , United States) -

13:45 Clinical implications of failed extubation James Krinsley ( Stamford , United States) -

14:00 Diaphragm dysfunction: Diagnosis and management Samir Jaber ( Montpellier , France) -

14:15 Ventilator dependency: From muscle wasting to weaning failureSteffen Weber-Carstens ( Berlin , Germany) -

14:30 Discussion

14:45 Weaning failure of cardiac origin Xavier Monnet ( Le Kremlin-Bicêtre , France) -

15:00 Fluid management during weaning Armand Mekontso Dessap ( Créteil , France) -

15:15 Do we need long-term weaning units? Timothy Walsh ( Edinburgh , United Kingdom) -

15:30 Discussion

15:45 Break

Biomarkers in sepsis [Standard presentation] Raquel Herrero ( Madrid, Spain) - John C Marshall ( Toronto ,Canada) -

16:05 Re-visiting the white blood cell count Axel Nierhaus ( Hamburg , Germany) -

16:20 Predicting outcome in CAP Salvador Bello ( Zaragoza, Spain) -

16:35 Mature adrenomedullin Alan S Maisel ( San Diego, United States) -

16:50 Discussion



17:00 Is adrenomedullin a friend or a foe? Peter Radermacher ( Ulm , Germany) -

17:15 Combining Pro-ADM and PCT Jaap van Dissel ( Leiden , Netherlands) -

17:30 Metabolic profilesAnthony Gordon ( London , United Kingdom) -

17:45 Discussion

400 HallCoagulation [Standard presentation] Jonathan Ball ( London , United Kingdom) - Stefan Hofer (Heidelberg , Germany) -

8:00 Optimizing heparin doses for thromboprophylaxis Paul Wischmeyer ( Aurora , United States) -

8:15 Bleeding with antiplatelet agents Giuseppe Biondi-Zoccai ( Rome, Italy) -

8:30 The pathogenesis of traumatic coagulopathy Beverley Hunt ( London , United Kingdom) -

8:45 Diagnosis of DIC in sepsis Kai Zacharowski ( Frankfurt , Germany) -

9:00 Discussion

9:15 Management of bleeding in sepsis Anders Perner ( Copenhagen , Denmark) -

9:30 Coagulation and anticoagulation in liver failure Alexander Wilmer ( Leuven , Belgium) -

9:45 Heparin-induced thrombocytopenia Daniel H Kett ( Miami , United States) -

10:00 Discussion

Fungal infections [Standard presentation] Steven Opal ( Providence , United States) - Antoni Torres (Barcelona , Spain) -

10:15 Beta-glucans in the diagnosis of fungal infections Thierry Calandra ( Lausanne , Switzerland) -

10:30 Beta-glucans to assess response to therapy Massimo Antonelli ( Rome , Italy) -

10:45 Aspergillus in tracheal aspirates: What should we do? Stijn Blot ( Ghent , Belgium) -

11:00 Can Candida cause septic shock? Marin Kollef ( St Louis , United States) -

11:15 Discussion

11:30 When to start antifungals in abdominal infections: Let us be INTENSE Jean-Louis Vincent ( Brussels , Belgium) -

11:45 The place for prophylactic or preemptive therapy Matteo Bassetti ( Udine, Italy) -

12:00 How to adapt antifungal drug doses? Patrick Honoré ( Brussels , Belgium) -

12:15 Are all echinocandins the same? Matteo Bassetti ( Udine, Italy) -

12:30 Discussion

Long-term outcomes [Standard presentation] Timothy Girard ( Nashville , United States) - John Myburgh (Sydney, Australia) -A recent multicenter study



13:30Timothy Walsh ( Edinburgh , United Kingdom) -

13:45 Neurocognitive outcomes are important Derek C Angus ( Pittsburgh , United States) -

14:00 Cerebral sequellae after severe hypoxemia Michael Quintel ( Göttingen , Germany) -

14:15 Discussion

14:30 Renal outcomes after acute renal failure Miet Schetz ( Leuven , Belgium) -

14:45 Are long-term outcomes any worse than for the rest of the hospital? Gordon Rubenfeld ( Toronto , Canada) -

15:00 Diabetes is not associated with worse outcomes in the critically ill James Krinsley ( Stamford , United States) -

15:15 Discussion

15:30 Break

Organ donation [Standard presentation] Sibylle Kozek-Langenecker ( Vienna , Austria) - Didier Ledoux (Liège , Belgium) -

15:50 Management of the potential organ donor Jonathan Ball ( London , United Kingdom) -

16:05 How to improve donor kidney quality Didier Payen ( Paris , France) -

16:20 Can goal-directed therapy work for brain-dead organ donors? John Kellum ( Pittsburgh , United States) -

16:35 Discussion

16:45 Organ donation after cardiac death in the ICU Scott D Halpern ( Philadelphia, United States) -

17:00 Organ donation from adults to children? Joe Brierley ( London, United Kingdom) -

17:15 Discussion

The ICU patient with systemic disease (Tu) [Tutorial] 17:25 The ICU patient with systemic disease

Jean-Daniel Chiche ( Paris , France) -

Lippens Room National LibraryNeuromonitoring [Standard presentation] Giuseppe Citerio ( Monza , Italy) - Niklas Nielsen ( Helsingborg,Sweden) -

8:00 Non-invasive ICP monitoring Thomas Geeraerts ( Toulouse , France) -

8:15 ICP or intracranial elastance Nino Stocchetti ( Milan , Italy) -

8:30 EEG monitoring Mauro Oddo ( Lausanne , Switzerland) -

8:45 Discussion

9:00 Multimodality monitoring Peter Le Roux ( Philadelphia, United States) -

9:15 Evaluating the effects of interventions on brain homeostasis Raimund Helbok ( Innsbruck , Austria) -

9:30 Discussion

9:45 Break



Neurological crises [Standard presentation] Jerry Nolan ( Bath , United Kingdom) - Mauro Oddo ( Lausanne, Switzerland) -

10:05 Update on meningitisKees Polderman ( Pittsburgh , United States) -

10:20 Imaging meningoencephalitis Isabelle Klein ( Paris, France) -

10:35 Posterior reversible encephalopathy syndrome Stephane Legriel ( Le Chesnay, France) -

10:50 Discussion

11:05 Unrecognized seizures Marek Mirski ( Baltimore , United States) -

11:20 Metabolic encephalopathy Fabio S Taccone ( Brussels , Belgium) -

11:35 Discussion

Prevention of VAP (Tu) [Tutorial] 11:50 Prevention of VAP

Jean Chastre ( Paris , France) -

Non-invasive ventilation [Standard presentation] Alexandre Mebazaa ( Paris , France) - Charles Phillips (Portland , United States) -

13:30 Outside the ICU Luca Cabrini ( Milan , Italy) -

13:45 For hemoncology patients Massimo Antonelli ( Rome , Italy) -

14:00 Should we give ‘do-not-intubate’ patients NIV? Elie Azoulay ( Paris , France) -

14:15 For postoperative and trauma patients Davide Chiumello ( Milan , Italy) -

14:30 Discussion

14:45 For obesity-hypoventilation syndrome Antoni Torres ( Barcelona , Spain) -

15:00 When not to use it David Tuxen ( Melbourne , Australia) -

15:15 NIV by helmet Giorgio A Iotti ( Pavia , Italy) -

15:30 Technical/clinical application of NIV Robert M Kacmarek ( Boston , United States) -

15:45 Discussion

16:00 Can we risk sedation? Andres Esteban ( Madrid , Spain) -

16:15 Optimal analgesia Samir Jaber ( Montpellier , France) -

16:30 SCCM latest guidelinesMichael Ramsay ( Dallas , United States) -

16:45 Discussion

Subarachnoid hemorrhage: Critical care management (Pl) [Plenary lecture]

17:00 Subarachnoid hemorrhage: Critical care management Giuseppe Citerio ( Monza , Italy) -

ECMO for cardiogenic shock (Pl) [Plenary lecture] 17:30 ECMO for cardiogenic shock

Alain Combes ( Paris , France) -



Studio (Bozar)Early diagnosis of infection [Standard presentation] Jean-Paul Mira ( Paris , France) - Andrew Rhodes ( London ,United Kingdom) -

8:00 Coagulase-negative staphylococcus in the blood: When is it really significant? Balasubramanian Venkatesh ( Brisbane , Australia) -

8:15 White blood cell gene expression: Clues to the etiology of infection Anthony McLean ( Sydney , Australia) -

8:30 Is streptococcus pneumoniae urinary antigen really of interest in CAP Eric Maury ( Paris , France) -

8:45 PCR microbiology Konrad Reinhart ( Jena , Germany) -

9:00 Discussion

9:15 Empiric antibiotic therapy for sepsis Thierry Calandra ( Lausanne , Switzerland) -

9:30 Do antibiotics really matter?Mervyn Singer ( London , United Kingdom) -

9:45 US to identify the source Eric Maury ( Paris , France) -

10:00 Discussion

10:15 Break

Do we need biomarkers? Revisited [Standard presentation] Sean Bagshaw ( Edmonton , Canada) - Robert Stevens (Baltimore , United States) -

10:40 Prognostic biomarkers for hospitalization: Use and misuse Beat Müller ( Aarau , Switzerland) -

10:55 Are all natriuretic peptides equal? Alexandre Mebazaa ( Paris , France) -

11:10 For acute cardiorenal dysfunction Alan S Maisel ( San Diego, United States) -

11:25 Discussion

11:35 For renal function Max Bell ( Stockholm, Sweden) -

11:50 In neurological patients Peter Le Roux ( Philadelphia, United States) -

12:05 What do we do with all these biomarkers in the ICU? Daiana Stolz ( Basel , Switzerland) -

12:20 Discussion

Electrical impedance tomography: 5-year clinical experience(Tu) [Tutorial]

13:30 Electrical impedance tomography: 5-year clinical experience Diederik Gommers ( Rotterdam , Netherlands) -

Diabetic emergencies (Tu) [Tutorial] 14:10 Diabetic emergencies

Ken Hillman ( Liverpool , Australia) -

The new oral anticoagulants (Tu) [Tutorial] 14:50 The new oral anticoagulants

Beverley Hunt ( London , United Kingdom) -

Comparing cooling technologies (Tu) [Tutorial] 15:30 Comparing cooling technologies

Kees Polderman ( Pittsburgh , United States) -

Bedside percutaneous tracheostomy (Tu) [Tutorial] 16:10 Bedside percutaneous tracheostomy

Marek Mirski ( Baltimore , United States) -

Managing the right ventricle (Tu) [Tutorial]



16:50 Managing the right ventricleMichael Pinsky ( Pittsburgh , United States) -

VILI (Tu) [Tutorial] 17:30 VILI

Marco Ranieri ( Turin , Italy) -

3/22/2013Gold Hall

The recent big fluid trials: Where to now? [Standardpresentation] Per-Olof Grände ( Lund , Sweden) - Scott D Halpern (Philadelphia, United States) -

8:00 The CHEST Trial: Further analyses John Myburgh ( Sydney, Australia) -

8:15 The CRYSTAL study Djillali Annane ( Garches , France) -

8:30 HES solutions after 6S and CHESTDavid Gattas ( Sydney , Australia) -

8:45 The ALBIOS study Luciano Gattinoni ( Milan , Italy) -

9:00 Discussion

9:15 Albumin in intensive care: Regulation and reimbursement issues Albert Farrugia ( Perth, Australia) -

9:30 What about different patient groups? Sibylle Kozek-Langenecker ( Vienna , Austria) -

9:45 Where are we now? Christian J Wiedermann ( Bolzano , Italy) -

10:00 Discussion

10:30 Break

Composition of i.v. fluids [Standard presentation] Ravindra Mehta ( San Diego , United States) - Markus Rehm (Munich , Germany) -

10:50 Saline and the kidney: The basics John Kellum ( Pittsburgh , United States) -

11:05 The clinical problem with chloride-rich fluids Rinaldo Bellomo ( Melbourne, Australia) -

11:20 Are balanced solutions ideal? Bertrand Guidet ( Paris , France) -

11:35 Discussion

11:45 Effects of artificial and biological colloids on renal function Michael Joannidis ( Innsbruck , Austria) -

12:00 Fluid choices for septic shock resuscitation Greg S Martin ( Atlanta , United States) -

12:15 Discussion

Transfusion [Standard presentation] Johan Decruyenaere ( Ghent , Belgium) - Jacques Duranteau (Le Kremlin-Bicêtre , France) -

13:30 Are we taking too much blood from our ICU patients? Kai Zacharowski ( Frankfurt , Germany) -

13:45 Death by blood transfusion Paul E Marik ( Norfolk , United States) -

14:00 Anemia or tansfusion: Which is worse?Aryeh Shander ( New York, United States) -

14:15 Effect on postoperative morbi-mortality: It depends on the indication Philippe Van Der Linden ( Brussels , Belgium) -



14:30 Discussion

14:45 RBC transfusion improves peripheral oxygenation Johan Groeneveld ( Rotterdam, Netherlands) -

15:00 Effects of transfusion on the microcirculation Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

15:15 Transfusions in neurocritical care: Where is the evidence? Alexis Turgeon ( Quebec , Canada) -

15:30 Should everyone have a transfusion trigger of 7 g/dL?Timothy Walsh ( Edinburgh , United Kingdom) -

15:45 Discussion

16:00 ScvO2 to guide transfusions Zsolt Molnar ( Szeged , Hungary) -

16:15 Age of stored RBCs: Potential implications Lorenzo Berra ( Boston, United States) -

16:30 Age of stored RBCs: But does it matter? Nicole Juffermans ( Amsterdam , Netherlands) -

16:45 Discussion

Copper HallSalvage therapies in ARDS [Standard presentation] Serge Brimioulle ( Brussels , Belgium) - Laurent Papazian (Marseille , France) -

8:00 Refractory hypoxemia Gordon Rubenfeld ( Toronto , Canada) -

8:15 Prone positioning Laurent Brochard ( Geneva , Switzerland) -

8:30 Still a place for inhaled NO? Jean-Daniel Chiche ( Paris , France) -

8:45 Still a place for HFOV? Niall Ferguson ( Toronto , Canada) -

9:00 Discussion

ARDS: Clinical [Standard presentation] Andres Esteban ( Madrid , Spain) - Paolo Pelosi ( Genoa ,Italy) -

9:30 Risk factors for TRALI in the critically ill Nicole Juffermans ( Amsterdam , Netherlands) -

9:45 Coagulation and genetics Jean-Paul Mira ( Paris , France) -

10:00 Fluid management in ARDS Daniel Reuter ( Hamburg , Germany) -

10:15 Update on pharmacological therapiesCarlos Santacruz Herrera ( Brussels, Belgium) -

10:30 Discussion

ARDS: Challenging the Berlin criteria [Standard presentation] Gordon Rubenfeld ( Toronto , Canada) - Mervyn Singer (London , United Kingdom) -

10:45 What are these criteria? Niall Ferguson ( Toronto , Canada) -

11:00 What are we really diagnosing? Andres Esteban ( Madrid , Spain) -

11:15 I like the Berlin criteria Laurent Brochard ( Geneva , Switzerland) -



11:30 I don’t like them Charles Phillips ( Portland , United States) -

11:45 Discussion

ARDS: Challenging the Berlin Criteria - Can we do better? [Round table]

12:00 ARDS: Challenging the Berlin criteria - Can we do better?Niall Ferguson ( Toronto , Canada) -

Luciano Gattinoni ( Milan , Italy) -

Michael Quintel ( Göttingen , Germany) -

Marco Ranieri ( Turin , Italy) -

Gordon Rubenfeld ( Toronto , Canada) -

Statistics for dummies (Tu) [Tutorial] 13:30 Statistics for dummies

Dominique Benoit ( Ghent , Belgium) -

ARDS: New ideas [Standard presentation] Philippe Jorens ( Edegem , Belgium) - Michael Quintel (Göttingen , Germany) -

14:10 Gene stem cell therapiesJohn G Laffey ( Toronto, Canada) -

14:25 Targeting apoptosis Raquel Herrero ( Madrid, Spain) -

14:40 Interferon betaGeoffrey Bellingan ( London , United Kingdom) -

14:55 Discussion

15:10 Heliox Nicole Juffermans ( Amsterdam , Netherlands) -

15:25 Fast CT assessment of lung recruitability Davide Chiumello ( Milan , Italy) -

15:40 Ion mobility spectrometry as a bedside tool to detect volatile compounds Michael Quintel ( Göttingen , Germany) -

15:55 Personalized treatment based on timing?Andres Esteban ( Madrid , Spain) -

16:10 Discussion

Salle M (Bozar)Massive bleeding [Standard presentation] Luca Cabrini ( Milan , Italy) - Alexander Wilmer ( Leuven ,Belgium) -

8:00 Hemorrhage control with tourniquets and dressings Rob Russell ( Birmingham, United Kingdom) -

8:15 Warfarin reversal Christian J Wiedermann ( Bolzano , Italy) -

8:30 Bleeding management in the era of novel oral anticoagulants Eddy Lang ( Calgary, Canada) -

8:45 Prothrombin complex concentrates vs FFPJoshua N Goldstein ( Boston, United States) -

9:00 How much FFP? Jeremy Henning ( Birmingham, United Kingdom) -

9:15 Discussion

9:30 Fibrinogen to boost coagulation Jacques Duranteau ( Le Kremlin-Bicêtre , France) -

9:45 Coagulation management in the bleeding patient Kai Zacharowski ( Frankfurt , Germany) -

10:00 Coagulation factor concentrates in severe bleeding



Sibylle Kozek-Langenecker ( Vienna , Austria) -

10:30 Obstetric hemorrhage Nicholas Kiefer ( Bonn , Germany) -

10:45 Discussion

11:00 Break

What I have learned from the military? [Standard presentation] Joshua N Goldstein ( Boston, United States) - Peter Radermacher ( Ulm , Germany) -

11:20 An overview of historical medical advances in war Michael Reade ( Herston QLD, Australia) -

11:35 Military trauma systems design Rob Russell ( Birmingham, United Kingdom) -

11:50 Military pre-hospital careJeremy Henning ( Birmingham, United Kingdom) -

12:05 Discussion

TentGlucose control: How tight? [Standard presentation] Richard Griffiths ( Liverpool , United Kingdom) - Johan Groeneveld ( Rotterdam, Netherlands) -

8:00 The influence of cytokines on glucose levels Hiroyuki Hirasawa ( Chiba , Japan) -

8:15 Glucose, muscle metabolism and atrophy Steffen Weber-Carstens ( Berlin , Germany) -

8:30 Diabetes, dysglycemia and outcome in the ICUJames Krinsley ( Stamford , United States) -

8:45 Glucose control in the pediatric ICU: Any long-term consequences? Greet Van Den Berghe ( Leuven , Belgium) -

9:00 Glucose control: How to quantify quality?Luc Foubert ( Aalst, Belgium) -

9:15 Discussion

9:30 Impact on short-term outcomes in heart failure Alexandre Mebazaa ( Paris , France) -

9:45 Glucose monitoring accuracy? Marcus Schultz ( Amsterdam , Netherlands) -

10:00 Are measurements from blood gas analyzers sufficient?Jean-Charles Preiser ( Brussels , Belgium) -

10:15 How to report performance of near-continuous glucose monitoring: A RoundTable consensus Jan Wernerman ( Stockholm , Sweden) -

10:30 Discussion

10:45 Break

Safer tracheostomy [Standard presentation] Davide Chiumello ( Milan , Italy) - Steffen Weber-Carstens (Berlin , Germany) -

11:05 Pros and cons of the six percutaneous techniques Luca Cabrini ( Milan , Italy) -

11:20 Ventilation during the procedure Giuseppe Foti ( Lecco, Italy) -

11:35 Minimizing risk during the procedureAxel Nierhaus ( Hamburg , Germany) -

11:50 Optimal humidification Paolo Pelosi ( Genoa , Italy) -



12:05 Prolonged tracheal intubation or tracheostomy? Andres Esteban ( Madrid , Spain) -

12:20 Discussion

Antibiotic management (Tu) [Tutorial] 13:30 Antibiotic management

Pieter Depuydt ( Gent , Belgium) -

Nosocomial infections [Standard presentation] Daniel H Kett ( Miami , United States) - Jaap van Dissel (Leiden , Netherlands) -

14:10 Risk and severity Pierre Damas ( Liège , Belgium) -

14:25 Selective decontamination of the digestive tract Evert De Jonge ( Leiden , Netherlands) -

14:40 C. difficile in the ICU Matteo Bassetti ( Udine, Italy) -

14:55 The role of bacterial biofilm Lorenzo Berra ( Boston, United States) -

15:10 Discussion

15:25 Are surveillance cultures helpful?Pieter Depuydt ( Gent , Belgium) -

15:40 Infection prevention and control by e-learning Stijn Blot ( Ghent , Belgium) -

15:55 Infection control practices in the ICU: What is the evidence? Daniel H Kett ( Miami , United States) -

16:10 Can statins improve outcomes? Laurent Papazian ( Marseille , France) -

16:25 Discussion

Silver HallBefore the emergency room [Standard presentation] Thomas Geeraerts ( Toulouse , France) - Ken Hillman (Liverpool , Australia) -

8:00 Oxygenation in the ambulance Paolo Pelosi ( Genoa , Italy) -

8:15 Point-of-care biology in the ambulance Jan Bakker ( Rotterdam , Netherlands) -

8:30 ECMO retrieval team Alain Combes ( Paris , France) -

8:45 Discussion

9:00 CPAP outside the hospital Giuseppe Foti ( Lecco, Italy) -

9:15 The future of emergency medical services as a medical subspecialty Raymond L Fowler ( Dallas , United States) -

9:30 Discussion

9:45 Break

Before the ICU [Standard presentation] Jacques Creteur ( Brussels , Belgium) - Arthur Van Zanten (Ede, Netherlands) -

10:05 Redefining resuscitation Ken Hillman ( Liverpool , Australia) -

10:20 Early warning systems on non-ICU wards Marin Kollef ( St Louis , United States) -



10:35 What should be measured? Rinaldo Bellomo ( Melbourne, Australia) -

10:40 Alternate designs for hospital rapid response systems David Gattas ( Sydney , Australia) -

10:55 Discussion

Continuous renal replacement therapy (Tu) [Tutorial] 11:10 Continuous renal replacement therapy

Ashita Tolwani ( Birmingham, United States) -

Imaging the brain (Tu) [Tutorial] 11:50 Imaging the brain

Isabelle Klein ( Paris, France) -

Renal replacement therapy [Standard presentation] Daniel De Backer ( Brussels , Belgium) - John Prowle ( London,United Kingdom) -

13:30 Timing and modality of RRT: Relationship to long-term outcomes John Kellum ( Pittsburgh , United States) -

13:45 How do physicians make the decision to initiate dialysis? Ravindra Mehta ( San Diego , United States) -

14:00 Still a place for peritoneal dialysis? Eric Hoste ( Ghent , Belgium) -

14:15 Discussion

14:30 Intermittent versus continuous RRT… or hybrid methods?Michael Joannidis ( Innsbruck , Austria) -

14:45 Does choice of RRT modality affect renal recovery? Rinaldo Bellomo ( Melbourne, Australia) -

15:00 Pediatric CRRT: New horizons Claudio Ronco ( Vicenza , Italy) -

15:15 Discussion

15:30 Ideal vascular accessPatrick Honoré ( Brussels , Belgium) -

15:45 Citrate anticoagulation for CRRT Ashita Tolwani ( Birmingham, United States) -

16:00 Practical management: Strategies to extend circuit lifespan John Prowle ( London, United Kingdom) -

16:15 Discussion

100 HallEnteral feeding [Standard presentation] Jan De Waele ( Ghent , Belgium) - Olav Rooyackers ( Huddinge, Sweden) -

8:00 Does the route really matter? Mette M Berger ( Lausanne , Switzerland) -

8:15 Timing matters Paul E Marik ( Norfolk , United States) -

8:30 Protocols for enteral feeding Jean-Charles Preiser ( Brussels , Belgium) -

8:45 Discussion

9:00 Results of the Metaplus trial Arthur Van Zanten ( Ede , Netherlands) -

9:15 Adding parenteral nutrition? Greet Van Den Berghe ( Leuven , Belgium) -

9:30 Adding probiotics? Arthur Van Zanten ( Ede , Netherlands) -



9:45 Discussion

10:00 Break

Delirium [Standard presentation] Jacques Berré ( Brussels , Belgium) - Alexis Turgeon ( Quebec ,Canada) -

10:20 Pathophysiology: We are less confused Robert Sanders ( London , United Kingdom) -

10:35 Effects of critical illness on cognitive function Timothy Girard ( Nashville , United States) -

10:50 Sleep disorders Stefan Hofer ( Heidelberg , Germany) -

11:05 Discussion

11:20 Noise control Philippe Jorens ( Edegem , Belgium) -

11:35 Targeting neuroinflammatory pathways with immunoglobulin treatment Figen Esen ( Istanbul , Turkey) -

11:50 Managing delirium in the ICU Timothy Girard ( Nashville , United States) -

12:05 Discussion

End-of-life care [Standard presentation] Bertrand Guidet ( Paris , France) - Jan A Hazelzet ( Rotterdam, Netherlands) -

13:30 Understanding treatment limitations in the ICU Rinaldo Bellomo ( Melbourne, Australia) -

13:45 Non-invasive ventilation Elie Azoulay ( Paris , France) -

14:00 Decisions to limit life support in the ICU: What explains the variability? Scott D Halpern ( Philadelphia, United States) -

14:15 Managing dying in the ICU Ken Hillman ( Liverpool , Australia) -

14:30 Discussion

14:45 Ethics in the pediatric ICU Matthew Bacchetta ( New York, United States) -

15:00 Should we be measuring the quality of ICU end-of-life care? Jeremy M Kahn ( Pittsburgh , United States) -

15:15 End of life care: From bedside to courtroom Gordon Rubenfeld ( Toronto , Canada) -

15:30 Discussion

Harnessing the power of internet for improved bedside care [Demonstration ]

15:45 Harnessing the power of the internet for improved bedside care Eddy Lang ( Calgary, Canada) -

400 HallICU quality assessment [Standard presentation] Lorenzo Berra ( Boston, United States) - Timothy Walsh (Edinburgh , United Kingdom) -

8:00 Evaluating healthcare quality Jan A Hazelzet ( Rotterdam , Netherlands) -

8:15 Limitations of using mortality as an outcome-indicator for benchmarking Evert De Jonge ( Leiden , Netherlands) -

8:30 New approaches using mortality as a quality measurement Jeremy M Kahn ( Pittsburgh , United States) -



8:45 The use of prognostic models for benchmarking quality of care in TBI Andrew I Maas ( Edegem , Belgium) -

9:00 Discussion

9:15 Break

The hypovolemic patient (Tu) [Tutorial] 9:35 The hypovolemic patient

Zsolt Molnar ( Szeged , Hungary) -

CNS monitoring in the ICU (Tu) [Tutorial] 10:05 CNS monitoring in the ICU

Thomas Geeraerts ( Toulouse , France) -

Respiratory infections [Standard presentation] Manu Malbrain ( Antwerp , Belgium) - Nicolo Patroniti ( Monza, Italy) -

10:55 Innate immunity in the lung: How pneumonia develops Jean-Daniel Chiche ( Paris , France) -

11:10 CAP and pneumococcal pneumonia Jean-Paul Mira ( Paris , France) -

11:25 CAP: Single or double coverage? Marcos Restrepo ( San Antonio , United States) -

11:40 Discussion

11:50 Corticosteroids in CAP: A two-edged sword? Antoni Torres ( Barcelona , Spain) -

12:05 Discussion

Management of severe hypoxemia (Pl) [Plenary lecture] 13:30 Management of severe hypoxemia

Nicolo Patroniti ( Monza , Italy) -

Necrotizing skin and soft tissue infections (Pl) [Plenary lecture]

14:00 Necrotizing skin and soft tissue infections Jan De Waele ( Ghent , Belgium) -

Early rehabilitation [Standard presentation] Mette M Berger ( Lausanne , Switzerland) - Greet Van DenBerghe ( Leuven , Belgium) -

14:30 Mechanisms of muscle wasting in the ICU Olav Rooyackers ( Huddinge , Sweden) -

14:45 Impact of early physiotherapy on muscle Steffen Weber-Carstens ( Berlin , Germany) -

15:00 Passive mobilization Jean-Charles Preiser ( Brussels , Belgium) -

15:15 Discussion

15:30 Does the diaphragm differ from limb muscles?Samir Jaber ( Montpellier , France) -

15:45 Total ICU rehabilitation Richard Griffiths ( Liverpool , United Kingdom) -

16:00 Discussion

Lippens Room National LibraryPostoperative complications [Standard presentation] Anthony Gordon ( London , United Kingdom) - Jan Poelaert (Brussels , Belgium) -

8:00 What is high-risk surgery? Rupert Pearse ( London , United Kingdom) -

8:15 Goal-directed hemodynamic management in high-risk surgery Daniel Reuter ( Hamburg , Germany) -

8:30 Outcomes in the high-risk patient Andrew Rhodes ( London , United Kingdom) -



8:45 The surgical patient as a model of critical illness Gareth Ackland ( London , United Kingdom) -

9:00 Discussion

9:15 Do we need biomarkers as prognostic indicators? Jaap van Dissel ( Leiden , Netherlands) -

9:30 Prediction and prevention of postoperative pulmonary complications Jaume Canet ( Barcelona, Spain) -

9:45 The importance of perioperative ventilatory settings Samir Jaber ( Montpellier , France) -

10:00 Discussion

10:15 Break

10:35 Preventing renal failure Sean Bagshaw ( Edmonton , Canada) -

10:50 Causes of perioperative acute kidney injury John Prowle ( London, United Kingdom) -

11:05 Arginine: Standard of care in high-risk surgery? Paul Wischmeyer ( Aurora , United States) -

11:20 Discussion

Treating the RIGHT ventricle (Pl) [Plenary lecture] 11:35 Treating the RIGHT ventricle

Steffen Rex ( Leuven, Belgium) -

Studio (Bozar)Guidelines and bundles [Standard presentation] Claudio Ronco ( Vicenza , Italy) - Julia Wendon ( London ,United Kingdom) -

8:00 Are guidelines wishful thinking? Jukka Takala ( Bern , Switzerland) -

8:15 Are guidelines for antibiotic use really helpful?Daniel H Kett ( Miami , United States) -

8:30 Cowboys in the ICU: Single patient studies Joe Brierley ( London, United Kingdom) -

8:45 Bundle, checklist and guideline implementation in critical care Derek C Angus ( Pittsburgh , United States) -

9:00 Discussion

9:15 Break

The limits of what we can provide [Standard presentation] Geoffrey Bellingan ( London , United Kingdom) - Joe Brierley (London, United Kingdom) -

9:40 How medical emergency teams can contribute Rinaldo Bellomo ( Melbourne, Australia) -

9:55 The frail patient Sean Bagshaw ( Edmonton , Canada) -

10:10 The elderly Bertrand Guidet ( Paris , France) -

10:25 Discussion

10:40 The elderly burn victim Mette M Berger ( Lausanne , Switzerland) -

10:55 The cancer patient Elie Azoulay ( Paris , France) -

11:10 Acute-on-chronic liver failure Julia Wendon ( London , United Kingdom) -



Home Perioperative Monitoring Refresher Course Echocardiography Rome Course(s) Main event page

Copyright 2007Legal notes

11:25 The perception of health care providers Dominique Benoit ( Ghent , Belgium) -

11:40 Discussion

Thromboelastography: We should use it more [Pro-con debate]

Kai Zacharowski ( Frankfurt , Germany) -11:55 Thromboelstography prophylaxis: We should use it more

PRO : Stefan Hofer ( Heidelberg , Germany) -

CON : Beverley Hunt ( London , United Kingdom) -

http://www.intensive.org/index.asp





http://www.intensive.org/1/main.asp

http://www.onetec.be/

Documents

33rd International Symposium on Intensive Care and Emergency … · 2016. 7. 15. · Traumatic brain injury [Standard presentation] 13:30 What is the Lund concept? Per-Olof ... pro